

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000560"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000560" />

    <meta name="citation_title" content="IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68"/>
    <meta itemprop="name" content="IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68"/>

      <meta name="citation_author" content="Gustavo T. Rosa"/>
            <meta name="citation_author_institution" content="Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom"/>
      <meta name="citation_author" content="Laurent Gillet"/>
            <meta name="citation_author_institution" content="Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom"/>
      <meta name="citation_author" content="Christopher M. Smith"/>
            <meta name="citation_author_institution" content="Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom"/>
      <meta name="citation_author" content="Brigitte D. de Lima"/>
            <meta name="citation_author_institution" content="Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom"/>
      <meta name="citation_author" content="Philip G. Stevenson"/>
            <meta name="citation_author_institution" content="Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom"/>

    <meta name="citation_date" content="2007/6/27"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000560.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e560"/>
    <meta name="citation_issue" content="6"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Protective ‘immunity’ by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called ‘immunological memory’.; citation_author=RM Zinkernagel; citation_author=H Hengartner; citation_journal_title=Immunol Rev; citation_volume=211; citation_number=1; citation_pages=310-319; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Variation and infectivity neutralization in influenza.; citation_author=M Knossow; citation_author=JJ Skehel; citation_journal_title=Immunology; citation_volume=119; citation_number=2; citation_pages=1-7; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=GP120: target for neutralizing HIV-1 antibodies.; citation_author=R Pantophlet; citation_author=DR Burton; citation_journal_title=Annu Rev Immunol; citation_volume=24; citation_number=3; citation_pages=739-769; " />
      <meta name="citation_reference" content="citation_title=A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals.; citation_author=QY Yao; citation_author=AB Rickinson; citation_author=MA Epstein; citation_journal_title=Int J Cancer; citation_volume=35; citation_number=4; citation_pages=35-42; citation_date=1985; " />
      <meta name="citation_reference" content="citation_title=Studies on the neutralization of herpes simplex virus. i. appearance of neutralizing antibodies having different grades of complement requirement.; citation_author=K Yoshino; citation_author=S Taniguchi; citation_journal_title=Virology; citation_volume=26; citation_number=5; citation_pages=44-53; citation_date=1965; " />
      <meta name="citation_reference" content="citation_title=Preparation of immune rabbit sera with neutralizing activity against human cytomegalovirus and varicella-zoster virus.; citation_author=LM Martos; citation_author=DV Ablashi; citation_author=RV Gilden; citation_author=RF Siguenza; citation_author=B Hampar; citation_journal_title=J Gen Virol; citation_volume=7; citation_number=6; citation_pages=169-171; citation_date=1970; " />
      <meta name="citation_reference" content="citation_title=Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines.; citation_author=G Miller; citation_author=JC Niederman; citation_author=DA Stitt; citation_journal_title=J Infect Dis; citation_volume=125; citation_number=7; citation_pages=403-406; citation_date=1972; " />
      <meta name="citation_reference" content="citation_title=Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro.; citation_author=IA Dialyna; citation_author=D Graham; citation_author=R Rezaee; citation_author=CE Blue; citation_author=NG Stavrianeas; citation_journal_title=AIDS; citation_volume=18; citation_number=8; citation_pages=1263-1270; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Isolation of five strains of herpesviruses from two species of free living small rodents.; citation_author=D Blaskovic; citation_author=M Stancekova; citation_author=J Svobodova; citation_author=J Mistrikova; citation_journal_title=Acta Virol; citation_volume=24; citation_number=9; citation_pages=468; citation_date=1980; " />
      <meta name="citation_reference" content="citation_title=Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis.; citation_author=SH Speck; citation_author=HW Virgin; citation_journal_title=Curr Opin Microbiol; citation_volume=2; citation_number=10; citation_pages=403-409; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=A mouse model for infectious mononucleosis.; citation_author=E Flano; citation_author=DL Woodland; citation_author=MA Blackman; citation_journal_title=Immunol Res; citation_volume=25; citation_number=11; citation_pages=201-217; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.; citation_author=PG Stevenson; citation_author=JM Boname; citation_author=B de Lima; citation_author=S Efstathiou; citation_journal_title=Microbes Infect; citation_volume=4; citation_number=12; citation_pages=1177-1182; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.; citation_author=RD Cardin; citation_author=JW Brooks; citation_author=SR Sarawar; citation_author=PC Doherty; citation_journal_title=J Exp Med; citation_volume=184; citation_number=13; citation_pages=863-871; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage.; citation_author=AJ Dal Canto; citation_author=HW Virgin; citation_author=SH Speck; citation_journal_title=J Virol; citation_volume=74; citation_number=14; citation_pages=11304-11310; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.; citation_author=JP Christensen; citation_author=RD Cardin; citation_author=KC Branum; citation_author=PC Doherty; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=96; citation_number=15; citation_pages=5135-5140; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Immunological control of a murine gammaherpesvirus independent of CD8+ T cells.; citation_author=PG Stevenson; citation_author=RD Cardin; citation_author=JP Christensen; citation_author=PC Doherty; citation_journal_title=J Gen Virol; citation_volume=80; citation_number=16; citation_pages=477-483; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells.; citation_author=S Ehtisham; citation_author=NP Sunil-Chandra; citation_author=AA Nash; citation_journal_title=J Virol; citation_volume=67; citation_number=17; citation_pages=5247-5252; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Lung epithelial cells are a major site of murine gammaherpesvirus persistence.; citation_author=JP Stewart; citation_author=EJ Usherwood; citation_author=A Ross; citation_author=H Dyson; citation_author=T Nash; citation_journal_title=J Exp Med; citation_volume=187; citation_number=18; citation_pages=1941-1951; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Antibody-mediated control of persistent gamma-herpesvirus infection.; citation_author=IJ Kim; citation_author=E Flano; citation_author=DL Woodland; citation_author=MA Blackman; citation_journal_title=J Immunol; citation_volume=168; citation_number=19; citation_pages=3958-3964; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.; citation_author=S Gangappa; citation_author=SB Kapadia; citation_author=SH Speck; citation_author=HW Virgin; citation_journal_title=J Virol; citation_volume=76; citation_number=20; citation_pages=11460-11468; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.; citation_author=PG Stevenson; citation_author=JS May; citation_author=XG Smith; citation_author=S Marques; citation_author=H Adler; citation_journal_title=Nat Immunol; citation_volume=3; citation_number=21; citation_pages=733-740; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Immune evasion by gamma-herpesviruses.; citation_author=PG Stevenson; citation_journal_title=Curr Opin Immunol; citation_volume=16; citation_number=22; citation_pages=456-462; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.; citation_author=S Kohl; citation_author=LS Loo; citation_journal_title=J Immunol; citation_volume=129; citation_number=23; citation_pages=370-376; citation_date=1982; " />
      <meta name="citation_reference" content="citation_title=Killing of virus-infected cells: the role of antiviral antibody and complement in limiting virus infection.; citation_author=JG Sissons; citation_author=MB Oldstone; citation_journal_title=J Infect Dis; citation_volume=142; citation_number=24; citation_pages=442-448; citation_date=1980; " />
      <meta name="citation_reference" content="citation_title=Kinetic analysis of the specific host response to a murine gammaherpesvirus.; citation_author=PG Stevenson; citation_author=PC Doherty; citation_journal_title=J Virol; citation_volume=72; citation_number=25; citation_pages=943-949; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo.; citation_author=PG Stevenson; citation_author=PC Doherty; citation_journal_title=J Virol; citation_volume=73; citation_number=26; citation_pages=1075-1079; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies.; citation_author=MB Gill; citation_author=L Gillet; citation_author=S Colaco; citation_author=JS May; citation_author=BD de Lima; citation_journal_title=J Gen Virol; citation_volume=87; citation_number=27; citation_pages=1465-1475; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines.; citation_author=JS Peiris; citation_author=JS Porterfield; citation_journal_title=Nature; citation_volume=282; citation_number=28; citation_pages=509-511; citation_date=1979; " />
      <meta name="citation_reference" content="citation_title=Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.; citation_author=ID Iankov; citation_author=M Pandey; citation_author=M Harvey; citation_author=GE Griesmann; citation_author=MJ Federspiel; citation_journal_title=J Virol; citation_volume=80; citation_number=29; citation_pages=8530-8540; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.; citation_author=KE Weck; citation_author=SS Kim; citation_author=HW Virgin; citation_author=SH Speck; citation_journal_title=J Virol; citation_volume=73; citation_number=30; citation_pages=3273-3283; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.; citation_author=E Flano; citation_author=SM Husain; citation_author=JT Sample; citation_author=DL Woodland; citation_author=MA Blackman; citation_journal_title=J Immunol; citation_volume=165; citation_number=31; citation_pages=1074-1081; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.; citation_author=JH Niess; citation_author=S Brand; citation_author=X Gu; citation_author=L Landsman; citation_author=S Jung; citation_journal_title=Science; citation_volume=307; citation_number=32; citation_pages=254-258; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=How the controller is controlled-neonatal Fc receptor expression and immunoglobulin G homeostasis.; citation_author=SW Qiao; citation_author=WI Lencer; citation_author=RS Blumberg; citation_journal_title=Immunology; citation_volume=120; citation_number=33; citation_pages=145-147; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.; citation_author=E Maidji; citation_author=S McDonagh; citation_author=O Genbacev; citation_author=T Tabata; citation_author=L Pereira; citation_journal_title=Am J Pathol; citation_volume=168; citation_number=34; citation_pages=1210-1226; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome.; citation_author=H Adler; citation_author=M Messerle; citation_author=M Wagner; citation_author=UH Koszinowski; citation_journal_title=J Virol; citation_volume=74; citation_number=35; citation_pages=6964-6974; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice.; citation_author=L Gillet; citation_author=MB Gill; citation_author=S Colaco; citation_author=CM Smith; citation_author=PG Stevenson; citation_journal_title=J Gen Virol; citation_volume=87; citation_number=36; citation_pages=3515-3527; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats.; citation_author=HM Coleman; citation_author=S Efstathiou; citation_author=PG Stevenson; citation_journal_title=J Gen Virol; citation_volume=86; citation_number=37; citation_pages=561-574; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Gamma-herpesvirus latency requires T cell evasion during episome maintenance.; citation_author=NJ Bennett; citation_author=JS May; citation_author=PG Stevenson; citation_journal_title=PLoS Biol; citation_volume=3; citation_number=38; citation_pages=e120; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7.; citation_author=Y Lee; citation_author=WJ Sohn; citation_author=DS Kim; citation_author=HJ Kwon; citation_journal_title=Eur J Biochem; citation_volume=271; citation_number=39; citation_pages=1094-1105; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68.; citation_author=JS May; citation_author=S Colaco; citation_author=PG Stevenson; citation_journal_title=J Virol; citation_volume=79; citation_number=40; citation_pages=3459-3467; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Viral degradation of the MHC class I peptide loading complex.; citation_author=JM Boname; citation_author=BD de Lima; citation_author=PJ Lehner; citation_author=PG Stevenson; citation_journal_title=Immunity; citation_volume=20; citation_number=41; citation_pages=305-317; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.; citation_author=PG Stevenson; citation_author=GT Belz; citation_author=MR Castrucci; citation_author=JD Altman; citation_author=PC Doherty; citation_journal_title=Proc Natl Acad Sci U S A.; citation_volume=96; citation_number=42; citation_pages=9281-9286; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.; citation_author=JM Lubinski; citation_author=M Jiang; citation_author=L Hook; citation_author=Y Chang; citation_author=C Sarver; citation_journal_title=J Virol; citation_volume=76; citation_number=43; citation_pages=9232-9241; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization.; citation_author=QY Yao; citation_author=M Rowe; citation_author=AJ Morgan; citation_author=CK Sam; citation_author=U Prasad; citation_journal_title=Int J Cancer; citation_volume=48; citation_number=44; citation_pages=45-50; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.; citation_author=MY Sangster; citation_author=DJ Topham; citation_author=S D'Costa; citation_author=RD Cardin; citation_author=TN Marion; citation_journal_title=J Immunol; citation_volume=164; citation_number=45; citation_pages=1820-1828; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressed.; citation_author=FX Mbopi-Keou; citation_author=J Legoff; citation_author=C Piketty; citation_author=H Hocini; citation_author=JE Malkin; citation_journal_title=AIDS.; citation_volume=18; citation_number=46; citation_pages=338-340; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Epithelial M cells: differentiation and function.; citation_author=JP Kraehenbuhl; citation_author=MR Neutra; citation_journal_title=Annu Rev Cell Dev Biol; citation_volume=16; citation_number=47; citation_pages=301-332; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes.; citation_author=T van Montfort; citation_author=AA Nabatov; citation_author=TB Geijtenbeek; citation_author=G Pollakis; citation_author=WA Paxton; citation_journal_title=J Immunol; citation_volume=178; citation_number=48; citation_pages=3177-3185; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Virological and pathological features of mice infected with murine gamma-herpesvirus 68.; citation_author=NP Sunil-Chandra; citation_author=S Efstathiou; citation_author=J Arno; citation_author=AA Nash; citation_journal_title=J Gen Virol; citation_volume=73; citation_number=49; citation_pages=2347-2356; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo.; citation_author=BD de Lima; citation_author=JS May; citation_author=PG Stevenson; citation_journal_title=J Virol; citation_volume=78; citation_number=50; citation_pages=5103-5112; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Glycoprotein L disruption reveals 2 functional forms of the murine gammaherpesvirus-68 glycoprotein H.; citation_author=L Gillet; citation_author=JS May; citation_author=S Colaco; citation_author=PG Stevenson; citation_journal_title=J Virol; citation_volume=81; citation_number=51; citation_pages=280-291; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Preparation of monoclonal antibodies: strategies and procedures.; citation_author=G Galfre; citation_author=C Milstein; citation_journal_title=Methods Enzymol; citation_volume=73; citation_number=52; citation_pages=3-46; citation_date=1981; " />
      <meta name="citation_reference" content="citation_title=Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection.; citation_author=L Gillet; citation_author=H Adler; citation_author=PG Stevenson; citation_journal_title=PLoS ONE; citation_volume=2; citation_number=53; citation_pages=e347; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread.; citation_author=JS May; citation_author=J Walker; citation_author=S Colaco; citation_author=PG Stevenson; citation_journal_title=J Virol; citation_volume=79; citation_number=54; citation_pages=5059-5068; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport.; citation_author=JS May; citation_author=BD de Lima; citation_author=S Colaco; citation_author=PG Stevenson; citation_journal_title=Traffic; citation_volume=6; citation_number=55; citation_pages=780-793; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Characterization of murine gammaherpesvirus 68 glycoprotein B.; citation_author=FB Lopes; citation_author=S Colaco; citation_author=JS May; citation_author=PG Stevenson; citation_journal_title=J Virol; citation_volume=78; citation_number=56; citation_pages=13370-13375; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection.; citation_author=PG Stevenson; citation_author=GT Belz; citation_author=JD Altman; citation_author=PC Doherty; citation_journal_title=Eur J Immunol; citation_volume=29; citation_number=57; citation_pages=1059-1067; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.; citation_author=L Liu; citation_author=E Flano; citation_author=EJ Usherwood; citation_author=S Surman; citation_author=MA Blackman; citation_journal_title=J Immunol; citation_volume=163; citation_number=58; citation_pages=868-874; citation_date=1999; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68"/>
    <meta name="twitter:description" content="BackgroundHerpesviruses can be neutralized in vitro but remain infectious in immune hosts. One difference between these settings is the availability of immunoglobulin Fc receptors. The question therefore arises whether a herpesvirus exposed to apparently neutralizing antibody can still infect Fc receptor+ cells.Principal FindingsImmune sera blocked murine gamma-herpesvirus-68 (MHV-68) infection of fibroblasts, but failed to block and even enhanced its infection of macrophages and dendritic cells. Viral glycoprotein-specific monoclonal antibodies also enhanced infection. MHV-68 appeared to be predominantly latent in macrophages regardless of whether Fc receptors were engaged, but the infection was not abortive and new virus production soon overwhelmed infected cultures. Lytically infected macrophages down-regulated MHC class I-restricted antigen presentation, endocytosis and their response to LPS.ConclusionsIgG Fc receptors limit the neutralization of gamma-herpesviruses such as MHV-68."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000560.g009"/>

  <meta property="og:title" content="IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=2230'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=8949'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=5455&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000560">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000560" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000560&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Gustavo T. Rosa, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Laurent Gillet, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Christopher M. Smith, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Brigitte D. de Lima, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Philip G. Stevenson
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:pgs27@cam.ac.uk">pgs27@cam.ac.uk</a></p>

                <p>Affiliation:
                  Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: June 27, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000560</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000560-g001" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g002" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g003" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g004" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g005" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g006" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g006" title="Figure 6">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g006&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g007" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g007" title="Figure 7">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g007&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g008" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g008" title="Figure 8">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g008&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-g009" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g009" title="Figure 9">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g009&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000560-t001" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000560">Reader Comments (1)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000560" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Herpesviruses can be neutralized in vitro but remain infectious in immune hosts. One difference between these settings is the availability of immunoglobulin Fc receptors. The question therefore arises whether a herpesvirus exposed to apparently neutralizing antibody can still infect Fc receptor<sup>+</sup> cells.</p>


<h3>Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>Immune sera blocked murine gamma-herpesvirus-68 (MHV-68) infection of fibroblasts, but failed to block and even enhanced its infection of macrophages and dendritic cells. Viral glycoprotein-specific monoclonal antibodies also enhanced infection. MHV-68 appeared to be predominantly latent in macrophages regardless of whether Fc receptors were engaged, but the infection was not abortive and new virus production soon overwhelmed infected cultures. Lytically infected macrophages down-regulated MHC class I-restricted antigen presentation, endocytosis and their response to LPS.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>IgG Fc receptors limit the neutralization of gamma-herpesviruses such as MHV-68.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Rosa GT, Gillet L, Smith CM, de Lima BD, Stevenson PG (2007) IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68. PLoS ONE 2(6):
          e560.
            doi:10.1371/journal.pone.0000560</p><p><strong>Academic Editor: </strong>Nina Papavasiliou, Rockefeller University, United States of America</p><p><strong>Received:</strong> April 20, 2007; <strong>Accepted:</strong> May 30, 2007; <strong>Published:</strong> June 27, 2007</p><p><strong>Copyright:</strong> © 2007 Rosa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>GTR and BdL were supported by a Portuguese Foundation for Science and Technology studentships. This work was supported by a Wellcome Trust (Senior Clinical Fellow GR076956MA to PGS) and grants from the Medical Research Council (G0400427, G9800903) and Cancer Research UK (C19612/A6189). LG is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS).</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Persistent viruses typically transmit infection by reactivating in immune hosts. Thus, they differ fundamentally from epidemic viruses, whose replication and transmission are blocked by established immunity. The chief defence against epidemic viruses is neutralizing antibody <a href="#pone.0000560-Zinkernagel1">[1]</a>, which mainly blocks receptor binding <a href="#pone.0000560-Knossow1">[2]</a>. How persistent viruses evade the same neutralization is not well understood. Some employ antigenic variation <a href="#pone.0000560-Pantophlet1">[3]</a>, but herpesviruses-arguably the most sophisticated of all persistent viruses-do not do so to any significant degree. Herpes virions are shed at low levels, while anti-viral antibody titers are often high <a href="#pone.0000560-Yao1">[4]</a>. And <em>in vitro</em> neutralization is abundantly documented <a href="#pone.0000560-Yoshino1">[5]</a>–<a href="#pone.0000560-Dialyna1">[8]</a>. However, virus carriers still spread infection. Standard <em>in vitro</em> neutralization assays therefore fail to capture some important aspects of infection <em>in vivo</em>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Our understanding of gamma-herpesvirus neutralization has been limited by the narrow species tropisms of Epstein-Barr virus (EBV) and the Kaposi's Sarcoma-associated Herpesvirus (KSHV). Both fail to reproduce their basic pathogenesis in experimental animals and propagate poorly <em>in vitro</em>, making related gamma-herpesviruses an important source of information. One of the most experimentally accessible is murine gamma-herpesvirus-68 (MHV-68), a natural, B cell-tropic parasite of yellow-necked mice <a href="#pone.0000560-Blaskovic1">[9]</a>–<a href="#pone.0000560-Stevenson1">[12]</a>. The basic mechanisms of host colonization appear to be quite similar between these viruses. However, their diseases are not-EBV and KSHV cause tumours, whereas MHV-68 pathologies primarily reflect lytic replication <a href="#pone.0000560-Cardin1">[13]</a>, <a href="#pone.0000560-DalCanto1">[14]</a>. Thus, MHV-68 models normal gamma-herpesvirus biology much better than it does human disease. Distinguishing normal host colonization from disease is important in pathogenesis studies. CD4<sup>+</sup> T cells <a href="#pone.0000560-Christensen1">[15]</a>, <a href="#pone.0000560-Stevenson2">[16]</a>, CD8<sup>+</sup> T cells <a href="#pone.0000560-Ehtisham1">[17]</a> and antibody <a href="#pone.0000560-Stevenson2">[16]</a>, <a href="#pone.0000560-Stewart1">[18]</a>–<a href="#pone.0000560-Gangappa1">[20]</a> can all protect against MHV-68-induced disease, because viral immune evasion operates poorly at high levels of lytic replication <a href="#pone.0000560-Stevenson3">[21]</a>, <a href="#pone.0000560-Stevenson4">[22]</a>. But host immunity fails to block herpesvirus transmission, because evasion dominates at low levels of lytic replication <a href="#pone.0000560-Stevenson3">[21]</a>, <a href="#pone.0000560-Stevenson4">[22]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Our aim with MHV-68 is to understand why established antibody responses do not prevent gamma-herpesvirus transmission. Standard MHV-68 pathogenesis studies have a limited capacity to answer this question as they focus on acute infection; by the time MHV-68-specific antibody is made, virus titers are low. And no MHV-68 transmission model yet exists. Immune sera protect antibody-deficient mice against disease <a href="#pone.0000560-Stevenson2">[16]</a>, <a href="#pone.0000560-Stewart1">[18]</a>–<a href="#pone.0000560-Gangappa1">[20]</a>, so antibody can damp down pathological lytic replication. But these studies have not distinguished neutralization from antibody-dependent cytotoxicity. Comparison with Herpes simplex virus <a href="#pone.0000560-Kohl1">[23]</a> would suggest that mainly the latter protects against disease <a href="#pone.0000560-Sissons1">[24]</a>. In contrast, blocking transmission must require neutralization.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>It is essential with MHV-68 not only to record <em>in vivo</em> phenomena but to identify the mechanisms behind them. Fortunately, MHV-68 offers several advantages for <em>in vitro</em> analysis: it is readily propagated and modified, cells with relevant deficiencies can be derived from knockout mice, and monoclonal antibodies can be generated from virus carriers. Our approach has therefore been first to understand as much as possible about neutralization <em>in vitro</em>. Immune sera appear to block MHV-68 infection of fibroblasts <a href="#pone.0000560-Stevenson5">[25]</a>, <a href="#pone.0000560-Stevenson6">[26]</a> primarily by blocking cell binding <a href="#pone.0000560-Gill1">[27]</a>. This raises questions about the robustness of neutralization, as antibody-coated viruses could still potentially infect macrophages and dendritic cells via immunoglobulin Fc receptors (FcRs) <a href="#pone.0000560-Peiris1">[28]</a>, <a href="#pone.0000560-Iankov1">[29]</a>. MHV-68 replicates in both these cell types <a href="#pone.0000560-Weck1">[30]</a>, <a href="#pone.0000560-Flano2">[31]</a>. And FcRs on intraepithelial dendritic cells <a href="#pone.0000560-Niess1">[32]</a> or epithelial FcRn <a href="#pone.0000560-Qiao1">[33]</a>, <a href="#pone.0000560-Maidji1">[34]</a> could allow antibody-coated virions to enter new hosts. We have tested here whether antibody-mediated MHV-68 neutralization applies equally to FcR<sup>+</sup> and FcR<sup>−</sup> cells. Our data suggest that FcRs allow otherwise neutralized virions to remain infectious and are therefore likely to compromise infection control.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>Immune sera fail to block MHV-68 infection of Fc receptor<sup>+</sup> cells</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Immune sera block MHV-68 infection of fibroblasts <a href="#pone.0000560-Stevenson5">[25]</a>, <a href="#pone.0000560-Stevenson6">[26]</a>. In order to test whether this neutralization applied also to FcR<sup>+</sup> cells, we incubated MHV-68 virions with sera from immune mice and then added the antibody-coated virions to either BHK-21 fibroblasts or RAW264.7 macrophages (<a href="#pone-0000560-g001">Fig. 1</a>). The virus used (BAC<sup>+</sup>) expresses eGFP from a human cytomegalovirus (HCMV) IE1 promoter, so eGFP expression provides a convenient marker of infection <a href="#pone.0000560-Adler1">[35]</a>. Immune sera inhibited BHK-21 cell infection but enhanced RAW264.7 cell infection (<a href="#pone-0000560-g001">Fig. 1A, 1B</a>). Naive sera had no effect (<a href="#pone-0000560-g001">Fig. 1B</a>), and neither heating immune sera (1 h, 56°C) nor adding exogenous mouse complement to untreated or heat-treated sera altered infection enhancement (data not shown). The enhancement was less obvious for peritoneal macrophages (<a href="#pone-0000560-g001">Fig. 1C</a>). However, all sera (n&gt;20) blocked fibroblast infection and failed to block RAW264.7 cell or peritoneal macrophage infections. Dendritic cell infection, this time measured by eGFP-tagged gM expression rather than HCMV IE1-driven eGFP, was also enhanced rather than blocked by immune serum (<a href="#pone-0000560-g001">Fig. 1D</a>). Immune sera enhanced BAC<sup>+</sup> MHV-68 infection of wild-type, bone marrow-derived macrophages, but inhibited the infection of IgG FcR-deficient macrophages (<a href="#pone-0000560-g002">Fig. 2</a>). Thus, the failure of antibody to inhibit macrophage infection was due to IgG FcRs, and RAW264.7 cell infection represented a general phenomenon of FcRs undermining virus neutralization.</p>
<div class="figure" id="pone-0000560-g001"><div class="img"><a name="pone-0000560-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Immune sera enhance MHV-68 infection of Fc receptor<sup>+</sup> cells.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p><strong>A.</strong> BAC<sup>+</sup> MHV-68 virions (4×10<sup>6</sup>PFU/ml) were incubated (1 h, 37°C) with sera from MHV-68-immune C57BL/6 mice. The serum/antibody mixtures were then added to BHK-21 fibroblasts (1PFU/cell) or RAW264.7 macrophages (3PFU/cell). 18h later infection was measured by flow cytometry of viral eGFP expression. Each line corresponds to 1 serum sample, pooled from 2 mice. The data are from 1 of 5 equivalent experiments. <strong>B.</strong> An equivalent experiment using sera from naive or MHV-68-immune BALB/c mice was analyzed by fluoresence microscopy. Each picture shows a 50% confluent culture of RAW264.7 cells. EGFP<sup>+</sup> cells appear black. <strong>C.</strong> BAC<sup>+</sup> MHV-68 virions and immune serum (20 µL/3×10<sup>5</sup>PFU) were incubated together (1 h, 37°C) and then divided between BHK-21 cells (0.3PFU/cell), murine embryo fibroblasts (MEF, 0.3PFU/cell), RAW264.7 cells (1PFU/cell) and peritoneal macrophages (1PFU/cell). Viral eGFP expression in each population was determined 18h later by flow cytometry. The data are from 1 of 3 equivalent experiments. CD19<sup>+</sup> peritoneal cells were always &lt;1% eGFP<sup>+</sup>. <strong>D.</strong> Bone marrow-derived dendritic cells or 293T epithelial cells were infected with MHV-68 (3PFU/cell) that expressed eGFP-tagged gM and had been pre-treated with 1% MHV-68-immune or naive mouse serum. 21 h later, gM-eGFP expression was quantitated by flow cytometry. Dendritic cells were CD11c<sup>+</sup> and co-stained for MHC class II as shown.</p>
<span>doi:10.1371/journal.pone.0000560.g001</span></div><div class="figure" id="pone-0000560-g002"><div class="img"><a name="pone-0000560-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>The effect of immune serum on macrophage infection depends on IgG Fc receptors.</span></strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>Wild-type and FceRIγ<sup>−/−</sup>FcγRIIB<sup>−/−</sup> (FcR<sup>−/−</sup>) bone marrow-derived macrophages were incubated overnight with BAC<sup>+</sup> MHV-68 (5PFU/cell) that had been preincubated with dilutions of serum from either naive or MHV-68-immune mice, and then analyzed for viral eGFP expression by flow cytometry. The dashed lines show the level of infection with no antibody. The data are from 1 of 3 equivalent experiments.</p>
<span>doi:10.1371/journal.pone.0000560.g002</span></div>

<h4>Viral glycoprotein-specific monoclonal antibodies (mAbs) can also enhance MHV-68 infection of Fc receptor<sup>+</sup> cells</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Immune sera comprise complex mixtures of antibody specificities, titers and isotypes. Thus, while they provide a useful measure of the overall host response, different components of that response can be hard to discern. For example, sera might contain both infection inhibiting and infection enhancing antibodies. We therefore tested a range of MHV-68 glycoprotein-specific mAbs for FcR-dependent infection (<a href="#pone-0000560-g003">Fig. 3</a>). Almost all glycoprotein-specific IgG mAbs enhanced RAW264.7 cell infection by BAC<sup>+</sup> MHV-68 to some degree. Gp150-specific mAbs were the most effective, but some enhancement could be seen even with mAbs specific for the neutralization targets gH/gL <a href="#pone.0000560-Gill1">[27]</a> and gB <a href="#pone.0000560-Gillet1">[36]</a> (<a href="#pone-0000560-g003">Fig. 3A</a>). Although we did not have sufficient mAbs for comprehensive testing, IgM mAbs tended to inhibit infection and IgG2a mAbs enhanced better than IgG1 or IgG2b (<a href="#pone-0000560-g003">Figure 3B</a>). As with serum-mediated enhancement, mAb-mediated enhancement was much reduced with FcR-deficient macrophages (<a href="#pone-0000560-g003">Fig. 3C, 3D</a>).</p>
<div class="figure" id="pone-0000560-g003"><div class="img"><a name="pone-0000560-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>MHV-68 glycoprotein-specific monoclonal antibodies enhance the infection of Fc receptor<sup>+</sup> cells.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p><strong>A.</strong> Purified BAC<sup>+</sup> virions (10<sup>6</sup>PFU/ml) were incubated (1 h, 37°C) either alone (virus only) or with isotyped-matched mAbs (all IgG2a at 10 µg/ml): gp150-T1A1, gH/gL-T2C12, gB-T7H9, gp48-6D10. MAbs LP2 (anti-HSV gD) and W6/32 (Anti-HLA-ABC) provided negative controls. The virion/antibody mixtures were added to RAW264.7 cells (3PFU/cell). Infection was quantitated 18h later by flow cytometry of viral eGFP expression. The data shown are representative of &gt;10 different experiments with at least 4 different mAbs tested for each viral protein. T2C12 is a neutralizing mAb, but 10 µg/ml corresponds to a sub-neutralizing dose for the amount of virus used. <strong>B.</strong> BAC<sup>+</sup> MHV-68 virions were incubated (1 h, 37°C) with no serum (virus only), 1% MHV-68-immune serum (imm serum), or mAbs of different isotypes as indicated (10 µg/ml) and then added to RAW264.7 cells (5PFU/cell). Viral eGFP expression was quantitated by flow cytometry 18h later. The data are from 1 of 5 equivalent experiments. <strong>C.</strong> Wild-type (WT) and FceRIγ<sup>−/−</sup>FcγRIIB<sup>−/−</sup> (FcR<sup>−/−</sup>) bone marrow-derived macrophages were incubated overnight with BAC<sup>+</sup> MHV-68 virions plus mAb dilutions as shown. T1A1 and T4G2 recognize gp150, 58-16D2 recognizes gp60 and Y3 is an H2-K<sup>b</sup>-specific control. The dashed lines show infection with no antibody for WT (coarse dashes) and FcR<sup>−/−</sup> macrophages (fine dashes). The data are from 1 of 3 equivalent experiments. <strong>D.</strong> Wild-type (WT) or CD16<sup>−/−</sup>CD32<sup>−/−</sup>CD64<sup>−/−</sup> (FcR<sup>−/−</sup>) bone marrow-derived macrophages were left uninfected (nil) or infected (3PFU/cell) with BAC<sup>+</sup> virions that had been preincubated or not (virus only) with gp150-specific mAbs as shown (T4G2, T1A1). Infection was quantitated 18 h later by flow cytometric assay of viral eGFP expression. Virus alone typically gave eGFP expression in 1–2% of bone marrow macrophages. The bars show mean±SD results from 3 experiments.</p>
<span>doi:10.1371/journal.pone.0000560.g003</span></div>

<h4>Increased viral eGFP expression correlates with other measures of infection</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Since the behaviour of an HCMV IE1 promoter in the context of the MHV-68 genome is unknown, we tested whether BAC<sup>+</sup> eGFP expression in RAW264.7 cells correlated with other markers of infection (<a href="#pone-0000560-g004">Fig. 4</a>). First, preincubating virions with a glycoprotein-specific mAb also gave more eGFP<sup>+</sup> cells when eGFP expression was driven by an endogenous MHV-68 promoter (<a href="#pone-0000560-g004">Fig. 4A</a>). We used that of ORF73, since it is active in latency as well as in lytic infection <a href="#pone.0000560-Coleman1">[37]</a>, <a href="#pone.0000560-Bennett1">[38]</a>. Second, a gp150-specific mAb increased both the dissemination of BAC<sup>+</sup> eGFP to new cells (<a href="#pone-0000560-g004">Fig. 4B</a>) and BAC<sup>+</sup> virus replication (<a href="#pone-0000560-g004">Fig. 4C</a>). FcR-dependent infection was therefore productive. Third, real-time PCR showed that pre-incubation with antibody increased the uptake of viral genomes (<a href="#pone-0000560-g004">Fig. 4D</a>) and eGFP-tagged (gM-eGFP) virions (<a href="#pone-0000560-g004">Fig. 4E</a>). Comparing neutral and low pH washes suggested mAbs primarily increased virus binding (<a href="#pone-0000560-g004">Fig. 4F</a>).</p>
<div class="figure" id="pone-0000560-g004"><div class="img"><a name="pone-0000560-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Antibody-dependent infection is productive and correlates with increased cell binding.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p><strong>A.</strong> MHV-68 expressing eGFP via an IRES inserted downstream of ORF73 was incubated with viral glycoprotein-specific mAbs as shown (100 µg/ml) and then incubated with RAW264.7 cells (5PFU/cell). UI = uninfected; vir only = virus without antibody. 18 h later viral eGFP expression was quantitated by flow cytometry. The data are from 1 of 3 equivalent experiments. <strong>B.</strong> BAC<sup>+</sup> MHV-68 was incubated with the gp150-specific mAb T4G2 (20 µg/ml) or with medium alone (1 h, 37°C) and then added to RAW264.7 cells (5PFU/cell). The cells were washed with PBS after 2h and then added to a 5-fold excess of uninfected RAW264.7 cells to monitor viral spread. Replicate cultures were analyzed for eGFP expression at the time points indicated. <strong>C.</strong> Replicate samples from the experiment in B, either with (+) or without (−) mAb preincubation for the initial infection, were divided into cell and supernatant (sup) fractions, frozen and thawed, and plaque assayed for infectious virus. The data are from 1 of 2 equivalent experiments. <strong>D.</strong> MHV-68 virions were incubated (1 h, 37°C) with 20 µg/ml mAb T4G2 (VIR+mAb) or with medium alone (VIR only), then added to RAW264.7 cells (8 h, 37°C). The cells were then washed in pH = 3 citrate buffer to remove accessible virus and lysed. Viral DNA content was quantitated by real-time PCR. Each bar shows mean±SD of 4 replicates. The data are from 1 of 2 equivalent experiments. <strong>E.</strong> MHV-68-gM-GFP was pre-incubated with mAb T1A1 (100 µg/10<sup>7</sup>PFU) (dotted line) or with medium only (1 h, 37°C) (dashed line), then added to RAW264.7 cells (5PFU/cell). The cells were washed with PBS after 4 h at 37°C, and assayed for gM-eGFP uptake by flow cytometry. <strong>F.</strong> gM-eGFP MHV-68 was incubated with RAW264.7 cells at different multiplicities with or without the gp150-specific mAb T7F5 (10 µg/ml). 4h later the cells were washed either in PBS or in pH = 3 citrate buffer (acid). gM-eGFP uptake was then assayed by flow cytometry. The data are from 1 of 2 equivalent experiments.</p>
<span>doi:10.1371/journal.pone.0000560.g004</span></div>

<h4>HCMV IE1 promoter activity underestimates macrophage infection</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>Although HCMV IE1 promoter-driven eGFP expression correlated with other measures of infection, it was unclear whether all infected cells were eGFP<sup>+</sup> and whether eGFP expression correlated mainly with lytic or latent viral gene expression. There is currently no definitive marker of MHV-68 latency. Thus, to test whether some eGFP<sup>−</sup> cells might also be infected we exploited the fact that the HCMV IE1 promoter is activated by LPS <a href="#pone.0000560-Lee1">[39]</a> and treated RAW264.7 cells exposed to MHV-68 with LPS (<a href="#pone-0000560-g005">Fig. 5A</a>). The number of eGFP<sup>+</sup> cells increased considerably. This was true even when LPS was added after removing the input virus, so it did not act by increasing infection. Instead, the HCMV IE1 promoter was active in only a minority of MHV-68-infected RAW264.7 cells. The same was true of peritoneal macrophages (see <a href="#pone-0000560-g006">Fig. 6A</a>). LPS had no effect on eGFP expression from the MHV-68 ORF73 promoter (data not shown).</p>
<div class="figure" id="pone-0000560-g005"><div class="img"><a name="pone-0000560-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>LPS reveals higher levels of RAW264.7 cell infection for both antibody-independent and antibody-dependent infections.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p><strong>A.</strong> RAW264.7 cells were left uninfected (UI) or incubated overnight with BAC<sup>+</sup> MHV-68 virions (2PFU/cell). LPS (100 ng/ml) was added to the infected cells for the full 18h, for 4h following infection, or not at all (virus only). Viral eGFP expression was then quantitated by flow cytometry. The bars show mean±SD of 3 replicate cultures. Equivalent results were obtained in 3 repeat experiments with RAW264.7 cells and 3 further experiments with peritoneal macrophages. <strong>B.</strong> RAW264.7 cells were incubated overnight with BAC<sup>+</sup> MHV-68 virions (2PFU/cell) with no LPS, with LPS for 4h before assay, or with LPS for the whole 18h. There was either no additional treatment (virus only), or the cultures were supplemented with the gp150-specific mAb T1A1 (10 µg/ml) or with LP2-treated HSV-1 virions. LP2, kindly provided by Ms. S.Bell (Division of Virology), is a gD-specific IgG2a neutralizing mAb and was added at concentrations sufficient to ablate HSV-1 infectivity (data not shown). Viral eGFP expression was measured by flow cytometry. The data are from 1 of 2 equivalent experiments.</p>
<span>doi:10.1371/journal.pone.0000560.g005</span></div><div class="figure" id="pone-0000560-g006"><div class="img"><a name="pone-0000560-g006" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g006&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g006"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g006&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g006/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g006/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g006/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g006/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g006.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g006/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g006/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g006.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 6.  <span>gM-eGFP expression but not HCMV IE1 promoter-driven eGFP expression correlates with ORF65 capsid expression in MHV-68-infected macrophages.</span></strong></p><a id="article1.body1.sec2.sec4.fig2.caption1.p1" name="article1.body1.sec2.sec4.fig2.caption1.p1"></a><p><strong>A.</strong> Peritoneal macrophages or BHK-21 fibroblasts were infected with BAC<sup>+</sup> MHV-68 (2PFU/cell and 0.5PFU/cell respectively). The macrophages were also treated or not with LPS (100 ng/ml). 18h later the cells were fixed in 4% paraformaldehyde and stained with the ORF65-specific mAb 12B8 plus Alexa 568-coupled goat anti-mouse IgG pAb (red). Nuclei were counterstained with DAPI (blue). eGFP was visualized directly (green). The data are from 1 of 3 equivalent experiments, and similar results were obtained with RAW264.7 cells. <strong>B.</strong> Peritoneal macrophages were infected as in <strong>A</strong> but with MHV-68 expressing eGFP-tagged gM, then fixed and stained for ORF65. The data are from 1 of 3 equivalent experiments, and similar results were obtained with RAW264.7 cells. C. RAW264.7 cells were left uninfected (UI) or infected overnight (2PFU/cell) with either BAC<sup>+</sup> or gM-eGFP MHV-68. The cells were stimulated with LPS (100 ng/ml) for a further 4 h to maximize HCMV IE1 promoter activity, then fixed, permeabilized with 0.1% Tween-20 and stained for ORF65 with mAb 12B8 plus Alexa 633-conjugated goat anti-mouse IgG pAb. Control = secondary antibody only. The percentage of cells in each quadrant is shown. The data are from 1 of 2 equivalent experiments.</p>
<span>doi:10.1371/journal.pone.0000560.g006</span></div><a id="article1.body1.sec2.sec4.p2" name="article1.body1.sec2.sec4.p2"></a><p>This result raised the possibility that increased eGFP expression by antibody reflected greater reporter gene expression as well as greater infection. We therefore tested the effect of antibody on BAC<sup>+</sup> eGFP expression in RAW264.7 cells with and without LPS (<a href="#pone-0000560-g005">Fig. 5B</a>). LPS increased eGFP expression in all samples, but the increase was similar for each. And adding neutralized HSV-1/IgG2a complexes to MHV-68-infected RAW264.7 cells did not increase their eGFP expression, arguing that Fc receptor engagement had little effect on the HCMV IE1 promoter. Thus, although HCMV IE1 promoter activity underestimated the total number of infected macrophages, it gave a good relative indication of infection in different populations, and this was increased by antibody. The fold increase in BAC<sup>+</sup> eGFP expression clearly depends in part on the basal level, so the fold increase in RAW264.7 cell infection was lower when LPS was included, in fact closer to that of primary macrophages. The difference in enhancement between these cell types may reflect that the HCMV IE1 promoter is more active in explanted primary macrophages. Again, the key point is not enhancement, but that in the presence of FcRs immune sera failed to neutralize.</p>


<h4>Most macrophages showing HCMV IE1 promoter activity are not lytically infected</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>Our second question was whether BAC eGFP<sup>+</sup> macrophages predominantly supported lytic or latent infection. We answered this by immunostaining infected peritoneal macrophages for the ORF65 capsid component (<a href="#pone-0000560-g006">Fig. 6</a>). Perinuclear capsids were observed in both eGFP<sup>+</sup> and eGFP<sup>−</sup> macrophages, consistent with endocytic virion uptake <a href="#pone.0000560-Gillet1">[36]</a>, but very few of either showed the strong nuclear staining typical of new capsid expression, as was seen in lytically infected BHK-21 cells (<a href="#pone-0000560-g006">Fig. 6A, 6C</a>). Thus, most BAC eGFP<sup>+</sup> macrophages appeared to be latently infected. This was also true of RAW264.7 cells, consistent with RAW264.7 cell cultures infected with BAC<sup>+</sup> MHV-68 and &gt;50% eGFP<sup>+</sup> containing much less infectious virus and surviving much longer than equivalent BHK-21 cell cultures (data not shown).</p>
<a id="article1.body1.sec2.sec5.p2" name="article1.body1.sec2.sec5.p2"></a><p>Even BHK-21 cells showed a limited correlation between BAC eGFP expression and nuclear capsid staining (<a href="#pone-0000560-g006">Fig. 6A</a>). Thus, the HCMV IE1 promoter operated independently of the rest of the MHV-68 genome: eGFP<sup>+</sup> cells were not necessarily lytic, and neither lytic nor latent cells were necessarily eGFP<sup>+</sup>. In contrast, the expression of eGFP-tagged gM from the endogenous gM promoter correlated closely with ORF65 expression (<a href="#pone-0000560-g006">Fig. 6B, 6C</a>), as is also seen in infected BHK-21 cells <a href="#pone.0000560-Gillet1">[36]</a>. The gM-eGFP virus therefore allowed us to identify lytically infected macrophages.</p>
<a id="article1.body1.sec2.sec5.p3" name="article1.body1.sec2.sec5.p3"></a><p>The contrast between BAC<sup>+</sup> eGFP and gM-eGFP was also evident for a virus that expressed both (<a href="#pone-0000560-g007">Fig. 7</a>). They can be distinguished because gM and gN concentrate in the trans-Golgi network and are excluded from the nucleus <a href="#pone.0000560-Adler1">[35]</a>, <a href="#pone.0000560-May1">[40]</a>-examples are indicated in <a href="#pone-0000560-g007">Figure 7A</a>-whereas free eGFP distributes uniformly. LPS treatment made gM-eGFP difficult to detect and massively increased BAC<sup>+</sup> eGFP. gM-eGFP may have been partly obscured by the increase in BAC<sup>+</sup> eGFP, but LPS also reduced gM-eGFP expression (see the eGFP<sup>+</sup> populations in <a href="#pone-0000560-g009">Fig. 9A</a>). The marked overall increase in total eGFP expression with LPS (<a href="#pone-0000560-g007">Fig. 7B</a>) therefore indicated that many MHV-68-exposed macrophages were infected but gM-eGFP<sup>−</sup>. These were presumably latently infected.</p>
<div class="figure" id="pone-0000560-g007"><div class="img"><a name="pone-0000560-g007" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g007&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g007"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g007&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g007/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g007/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g007/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g007/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g007.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g007/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g007/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g007.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 7.  <span>BAC+eGFP and gM-eGFP are differentially affected by LPS.</span></strong></p><a id="article1.body1.sec2.sec5.fig1.caption1.p1" name="article1.body1.sec2.sec5.fig1.caption1.p1"></a><p><strong>A.</strong> RAW264.7 cells were infected with BAC<sup>+</sup>gM-eGFP<sup>+</sup> MHV-68 (2PFU/cell, 18 h), then treated for 4 h with LPS (100 ng/ml). The cells were then fixed and examined for eGFP expression (green). Nuclei were counterstained with DAPI (blue). The thick arrows show gM-eGFP<sup>+</sup> cells and the thin arrows BAC<sup>+</sup> eGFP<sup>+</sup> cells. <strong>B.</strong> RAW264.7 cells were infected with BAC<sup>+</sup>gM-eGFP<sup>+</sup> MHV-68 at different multiplicities. 18 h later the cells were treated for 4 h with LPS (100 ng/ml). Total eGFP expression (BAC<sup>+</sup> eGFP plus gM-eGFP) was then quantitated by flow cytometry.</p>
<span>doi:10.1371/journal.pone.0000560.g007</span></div>

<h4>Functional characterization of MHV-68-infected macrophages</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>MHV-68-infected macrophage cultures evidently contain a mixture of uninfected, lytically infected and latently infected cells. Assays of function that fail to distinguish these populations are therefore hard to interpret. We focussed on the lytic (gM-eGFP<sup>hi</sup>) infection phenotype. Flow cytometry established that approximately 50% of lytically infected RAW264.7 cells had down-regulated cell surface MHC class I expression (<a href="#pone-0000560-g008">Fig. 8A</a>). Similar results were obtained for peritoneal macrophages (data not shown). The down-regulation was not reversed by IFN-γ, indeed it became more obvious. This was consistent with K3 function, since the MHV-68 K3 degrades TAP more efficiently in cells treated with IFN-γ <a href="#pone.0000560-Boname1">[41]</a>. K3 function was confirmed by comparing antigen presentation from peritoneal macrophages infected with wild-type and K3 knockout viruses (<a href="#pone-0000560-g008">Fig. 8B</a>): K3 disruption markedly increased the stimulation of a lytic antigen-specific T cell hybridoma. Comparison with a peptide titration curve suggested that K3 reduced antigen presentation 10-100-fold. The population with intermediate eGFP expression in <a href="#pone-0000560-g008">Fig. 8A</a> presumably derived its gM-eGFP from incoming virions or phagocytosed infected cell debris, and contained both latently infected and uninfected cells (see <a href="#pone-0000560-g007">Figure 7</a>). These showed no evidence of MHC class I down-regulation. Thus, K3 may not be transcribed in latently infected macrophages.</p>
<div class="figure" id="pone-0000560-g008"><div class="img"><a name="pone-0000560-g008" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g008&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g008"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g008&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g008/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g008/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g008/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g008/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g008.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g008/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g008/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g008.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 8.  <span>MHV-68 inhibits MHC class I-restricted antigen presentation in macrophages.</span></strong></p><a id="article1.body1.sec2.sec6.fig1.caption1.p1" name="article1.body1.sec2.sec6.fig1.caption1.p1"></a><p><strong>A.</strong> RAW264.7 cells were infected overnight with gM-eGFP MHV-68 (2PFU/cell), treated or not with IFNγ (20 U/ml) for a further 24 h, then stained for cell surface MHC class I. The data are from 1 of 2 equivalent experiments. <strong>B.</strong> Peritoneal macrophages from C57BL/6 mice were left uninfected (UI), infected overnight with wild-type (WT) or K3-deficient (K3<sup>−</sup>) MHV-68 at different multiplicities, or incubated with dilutions of the immunodominant H2-D<sup>b</sup>-restricted MHV-68 peptide p56, to relate viral recognition to an equivalent peptide concentration. A p56-specific lacZ<sup>+</sup> T cell hybridoma was added the next day and β-galactosidase expression assayed by ELISA after a further 20 h. Each bar shows mean±SD results of triplicate cultures. The data are from 1 of 2 equivalent experiments. Similar results were also obtained with bone marrow-derived macrophages.</p>
<span>doi:10.1371/journal.pone.0000560.g008</span></div><a id="article1.body1.sec2.sec6.p2" name="article1.body1.sec2.sec6.p2"></a><p>Lytically infected RAW264.7 cells showed similar spontaneous TNF-α expression to uninfected cells (<a href="#pone-0000560-g009">Fig. 9A</a>), but less increase in expression with LPS. They also failed to up-regulate IL-6 or CD86. Each function may be specifically inhibited, or lytically infected RAW264.7 cells may no longer respond to LPS. Lytically infected RAW264.7 cells also showed less endocytic uptake of fluorochrome-labelled dextran or 0.2 µm beads (<a href="#pone-0000560-g009">Fig. 9B</a>). Based on LPS-stimulated, BAC eGFP expression, many of the cells in the <a href="#pone-0000560-g009">Fig. 9</a> cultures would have been latently infected. In contrast to lytic infection, this was not associated with obvious functional abnormalities.</p>
<div class="figure" id="pone-0000560-g009"><div class="img"><a name="pone-0000560-g009" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g009&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.g009"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.g009&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g009/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g009/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g009/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g009/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g009.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.g009/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.g009/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.g009.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 9.  <span>Lytically infected macrophages show multiple functional abnormalities.</span></strong></p><a id="article1.body1.sec2.sec6.fig2.caption1.p1" name="article1.body1.sec2.sec6.fig2.caption1.p1"></a><p><strong>A.</strong> Peritoneal macrophages were infected overnight with gM-eGFP MHV-68 (2PFU/cell), treated or not with LPS (100 ng/ml) for a further 6h in the presence of brefeldin-A, then fixed, permeabilized and stained for IL-6 or TNF-α. Cells infected and stimulated the same way, but without brefeldin-A, were stained for CD86 without permeabilization. The data are from 1 of 2 equivalent experiments. <strong>B.</strong> Peritoneal macrophages were left uninfected or infected overnight with gM-eGFP MHV-68 (2PFU/cell), then incubated with 0.2 µm Crimson (625/624) Fluospheres or Alexa 647-conjugated dextran (molecular weight 10 kDa). After 90 min at 4°C (for no endocytosis) or 37°C (for endocytosis) the cells were washed and analyzed by flow cytometry. The infected populations were gated according to high gM-eGFP expression (thick red lines, corresponding to lytic infection) or low gM-eGFP expression (thin black lines, corresponding to no infection or latent infection) and then assayed for red fluorescence. The data are from 1 of 3 equivalent experiments.</p>
<span>doi:10.1371/journal.pone.0000560.g009</span></div>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>Immune responses generally protect against gamma-herpesvirus-induced disease but fail to prevent viral transmission. Viral inhibition of antigen presentation provides a window of T cell escape <a href="#pone.0000560-Stevenson4">[22]</a>. But how do virions evade neutralization by antibody when they are shed from immune hosts? This is different to evading antibody-dependent cytotoxicity within hosts. Indeed, the gammaherpesviruses, which colonize single hosts mainly by latency-associated lymphoproliferation <a href="#pone.0000560-Stevenson7">[42]</a>, lack the IgG FcR homologs associated with evading antibody-dependent cytotoxicity <a href="#pone.0000560-Lubinski1">[43]</a>. Here we have shown that immune sera fail to block FcR-mediated MHV-68 infection. Thus, while the natural antibody response blocks cell binding <a href="#pone.0000560-Gill1">[27]</a>, it evidently fails to inactivate the key process of membrane fusion. Accessory uptake routes such as that provided by FcRs may therefore allow gammaherpes virions to remain infectious when leaving immune hosts.</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>Virions leaving a persistently infected host or entering a new, naive host traverse complex, dynamic environments. Precisely what infection opportunities and obstacles they encounter are unknown. However, immune hosts shed only small numbers of virions and can have quite high antibody titers, both in serum and mucosal secretions <a href="#pone.0000560-Yao2">[44]</a>. Exiting virions should therefore meet sufficient antibody to neutralize them if neutralization were efficient. MHV-68 neutralization was clearly limited in scope. Neutralizing mAbs can block fusion <a href="#pone.0000560-Gill1">[27]</a>, <a href="#pone.0000560-Adler1">[35]</a>, but are quite rare in virus carriers and do not work well. Thus, the whole response blocks fusion poorly. We focussed on serum antibody, but the specificities in mucosal secretions are unlikely to be substantially different. Immunoglobulin transport may enrich mucosal secretions for IgA, but the IgA response to MHV-68 is minimal <a href="#pone.0000560-Sangster1">[45]</a> and much of the KSHV-specific antibody in mucosal secretions is IgG <a href="#pone.0000560-MbopiKeou1">[46]</a>. Serum antibody is therefore probably not dissimilar to what an exiting virus would meet.</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>If epithelial binding is blocked by antibody, antigen sampling and immunoglobulin homeostasis at mucosal surfaces could provide important routes of infection. It might even be considered that the normal infectious particle is an antibody-coated virion. FcRn takes up IgG in adults as well as neonates <a href="#pone.0000560-Qiao1">[33]</a>; FcR<sup>+</sup> myeloid cells access the mucosal lumen <a href="#pone.0000560-Niess1">[32]</a>; and M cells provide transcytosis to submucosal FcRs <a href="#pone.0000560-Kraehenbuhl1">[47]</a>. The fate of incoming virions may therefore depend on their capacity to infect after FcR-mediated uptake. We studied the fate of antibody-coated MHV-68 in macrophages because the destruction of antibody-coated particles is a major part of their function. Antibody-coated MHV-68 escaped this fate. Thus, MHV-68 should be able to escape from the endosomes of other cells too, indeed it normally infects fibroblasts via a low pH-dependent endocytic route <a href="#pone.0000560-Gill1">[27]</a>. We saw no obvious functional difference between antibody-independent and antibody-dependent macrophage infections. In both cases, MHV-68 remained largely latent for at least 24h, as measured by an absence of lytic gene expression. Latently infected macrophages were functionally indistinguishable from uninfected controls. On switching to lytic infection, MHV-68 inhibited a range of macrophage functions, including MHC class I-restricted antigen presentation, and produced new virions. Thus, FcR-mediated uptake fully restored the infectivity of virions coated with serum antibody. The uptake of antibody-coated viruses by lectins <a href="#pone.0000560-vanMontfort1">[48]</a> may achieve the same end.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>Once MHV-68 has entered a new host, there is no detectable viraemia <a href="#pone.0000560-SunilChandra1">[49]</a> and viruses lacking gp150, which have a defect in virion release <a href="#pone.0000560-deLima1">[50]</a>, or lacking gL, which have a defect in virion binding <a href="#pone.0000560-Gillet2">[51]</a>, appear remarkably normal. Host colonization therefore depends more on cell/cell spread and virus-driven B cell proliferation than on the release of cell-free virions. The capacity of immune serum to damp down lytic replication in this setting probably reflects antibody-dependent cytotoxicity. However, antibody could also divert infection from epithelial cells and fibroblasts, where it is predominantly lytic, to FcR<sup>+</sup> cells, where it is predominantly latent. This would appear as protection even without an anti-viral effect. Such considerations emphasize the need to understand the molecular mechanisms behind <em>in vivo</em> phenomena. These are rarely so straightforward as they first appear.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Mice and cells</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>BALB/c and C57BL/6J mice were purchased from Harlan U.K. Ltd. (Bicester, U.K.), housed in the Cambridge University Department of Pathology and infected intranasally with 2×10<sup>4</sup>PFU MHV-68 when 6–8 weeks old (Home Office Project Licence 80/1579). Immune sera were collected at 3–6 months post-infection, by which time the viral load and serum antibody have reached steady state <a href="#pone.0000560-Stevenson5">[25]</a>, <a href="#pone.0000560-Stevenson6">[26]</a>. Macrophages were derived from bone marrow progenitors by culture in RPMI with 10% fetal calf serum, 5% horse serum, 50 µM 2-mercaptoethanol, 2 mM glutamine, 100U/ml penicillin, 100 µg/ml streptomycin, 1 mM pyruvate and 20% L929-conditioned medium. New medium was supplied every 3–4 d and the adherent cells (&gt;95% CD11b<sup>+</sup>F4/80<sup>+</sup>) harvested after 7–14 d. Peritoneal macrophages were obtained by peritoneal lavage of naive mice with Dulbecco's modified Eagle medium plus 5% fetal calf serum. Cells not adherent to tissue culture plates (45 min, 37°C) were discarded. The adherent cells were 80–85% CD11b<sup>+</sup>CD11c<sup>−</sup>F4/80<sup>+</sup>CD19<sup>−</sup>. In flow cytometry-based assays, FSC/SSC gating increased this to &gt;95%. Dendritic cells were grown from bone marrow progenitors in RPMI with 10% fetal calf serum, 50 µM 2-mercaptoethanol, 100 U/ml penicillin, 100 µg/ml streptomycin and 7.5ng/ml GM-CSF. Bone marrow cells were first put on tissue culture plates (30 min, 37°C) and the adherent (macrophage-rich) cells discarded. The culture medium was changed every 2d. After 3d, non-adherent (granulocyte-rich) cells were discarded. After 7d, the non-adherent cells (90% CD11c<sup>+</sup>MHC class II<sup>+</sup>Gr1<sup>−</sup>) were harvested. BHK-21 cells, RAW264.7 cells and 293T cells were grown in Dulbecco's modified Eagle medium with 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10% fetal calf serum. Murine embryo fibroblasts were cultured in the same medium plus 50 µM 2-mercaptoethanol.</p>


<h4>Viruses</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>Infectious MHV-68 was derived from a genomic BAC, which contains eGFP with an HCMV IE-1 promoter as part of a loxP-flanked BAC cassette <a href="#pone.0000560-Adler1">[35]</a>. Except when eGFP expression was used as a marker of infection (BAC<sup>+</sup> virus), the BAC cassette was removed by passaging the virus through NIH-3T3-CRE cells <a href="#pone.0000560-Stevenson3">[21]</a>. MHV-68 expressing either eGFP fused to the C-terminus of glycoprotein M or eGFP downstream of ORF73 via an IRES have been described <a href="#pone.0000560-Adler1">[35]</a>, <a href="#pone.0000560-Bennett1">[38]</a>. All viruses were grown in BHK-21 cells. Infected cultures were cleared of infected cell debris by low-speed centrifugation (1000×<em>g</em>, 3 min). Virions were then concentrated from supernatants by high speed centrifugation (38000×<em>g</em>, 90 min). Virus titers were determined by plaque assay on BHK-21 cells <a href="#pone.0000560-vanMontfort1">[48]</a>.</p>


<h4>Flow cytometry</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>Cells exposed to eGFP<sup>+</sup> viruses were washed in PBS and analysed directly for green fluorescence. To assay endocytosis, macrophages were incubated with Alexa 647-conjugated 10kDa dextran (Invitrogen) at 100 µg/ml or 0.2 µm Crimson (625/645) Fluospheres (Invitrogen) at 2×10<sup>9</sup> beads/ml, washed in PBS and analysed for red fluorescence. For surface staining, cells were incubated (1h, 4°C) with MHV-68 glycoprotein-specific mAbs followed by fluorescein-conjugated rabbit anti-mouse IgG pAb (Dako Cytomation) or Alexa 633-conjugated or Alexa 488-conjugated goat anti-mouse IgG pAb (Invitrogen). Fluorescent conjugates of mAbs against CD86, CD11c, CD11b, F4/80, MHC class II or MHC class I were from BD Biosciences. For intracellular cytokine staining, cells were fixed in 1% paraformaldehyde (30 min), permeabilized with 0.1% saponin, and incubated with phycoerythrin-conjugated rat anti-mouse IL-6 or anti-mouse TNF-α mAbs (BD Biociences). For ORF65 staining, cells were permeabilized in 0.1% Tween-20 after fixation and incubated with mAb 12B8 followed by Alexa 633-conjugated goat anti-mouse IgG pAb. Cells were washed with PBS after antibody staining and analysed on a FACS Calibur using Cellquest software (BD Biosciences).</p>


<h4>Immunofluorescence</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>Adherent cells were washed in PBS, fixed in 2% paraformaldehyde and permeabilized with 0.1% Tween-20. EGFP fluorescence was visualized directly. The MHV-68 ORF65 capsid component was stained with mAb 12B8 <a href="#pone.0000560-Gillet1">[36]</a> plus Alexa 568-conjugated goat anti-mouse IgG pAb (Invitrogen). Nuclei were counterstained with DAPI. Fluorescence was visualized with an Olympus IX70 microscope plus a Retiga 2000R camera line (QImaging).</p>


<h4>Monoclonal antibodies</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>MHV-68 glycoprotein-specific hybridomas were all derived from MHV-68-infected mice by fusing spleen cells with NS0 cells <a href="#pone.0000560-Galfre1">[52]</a>. Their specificities were determined by flow cytometric analysis of cells infected with wild-type or glycoprotein-mutant viruses, or transfected with recombinant glycoproteins. The mAbs used in this study are listed in <a href="#pone-0000560-t001">Table 1</a>. Isotypes were determined by ELISA (Sigma Chemical Co.). Antibody was concentrated from hybridoma supernatants by ammonium sulfate precipitation and quantitated by ELISA using isotype-matched standards.</p>
<div class="figure" id="pone-0000560-t001"><div class="img"><a name="pone-0000560-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000560" data-uri="info:doi/10.1371/journal.pone.0000560.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000560.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000560.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000560.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000560.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000560.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>MHV-68 glycoprotein-specific mAbs used in this study.</span></strong></p><span>doi:10.1371/journal.pone.0000560.t001</span></div>

<h4>Viral DNA quantitation</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>DNA was extracted from infected cells and a portion of the MK3 ORF (genomic co-ordinates 24832-25071) amplified by real-time PCR <a href="#pone.0000560-Bennett1">[38]</a>. PCR products were quantitated with Sybr green (Invitrogen) and compared with a standard curve of cloned template. K3 content was normalized by comparison with beta actin, amplified from replicate samples.</p>


<h4>Antigen presentation assay</h4>
<a id="article1.body1.sec4.sec7.p1" name="article1.body1.sec4.sec7.p1"></a><p>Peritoneal macrophages from C57BL/6 (H2<sup>b</sup>) mice were infected with wild-type or K3-deficient <a href="#pone.0000560-Stevenson3">[21]</a> MHV-68 (2PFU/cell) or incubated with p56 peptide, which corresponds to an immunodominant H2-D<sup>b</sup>-restricted MHV-68 epitope from ORF6 <a href="#pone.0000560-Stevenson8">[57]</a>. 18h later a T cell hybridoma was added which produces β-galactosidase in response to p56+H2-D<sup>b</sup> [59]. After a further 18h, the cells were washed ×1 in PBS and lysed in PBS/5 mM MgCl<sub>2</sub>/1% NP-40/0.15 µM chlorophenol-red-beta-D-galactoside (Merck Biosciences) to assay beta-galactosidase activity. The absorbance at 595nm was read on a Biorad Benchmark Microplate Reader.</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We thank Piero Mastroeni and Sjef Verbeek for bone marrow from CD16<sup>−/−</sup>CD32<sup>−/−</sup>CD64<sup>−/−</sup> mice. All MHV-68-specific hybridomas were derived and maintained by Susanna Colaco. Valuable technical assistance was also provided by Janet May.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: PS LG GR Bd CS. Performed the experiments: PS LG GR Bd CS. Analyzed the data: PS LG GR Bd CS. Wrote the paper: PS.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000560-Zinkernagel1" id="pone.0000560-Zinkernagel1"></a>Zinkernagel RM, Hengartner H (2006) Protective ‘immunity’ by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called ‘immunological memory’. Immunol Rev  211: 310–319.  <ul class="find" data-citedArticleID="961640" data-doi="10.1111/j.0105-2896.2006.00402.x"><li><a href="http://dx.doi.org/10.1111/j.0105-2896.2006.00402.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Protective+%26%23x2018%3Bimmunity%26%23x2019%3B+by+pre-existent+neutralizing+antibody+titers+and+preactivated+T+cells+but+not+by+so-called+%26%23x2018%3Bimmunological+memory%26%23x2019%3B." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Protective+%26%23x2018%3Bimmunity%26%23x2019%3B+by+pre-existent+neutralizing+antibody+titers+and+preactivated+T+cells+but+not+by+so-called+%26%23x2018%3Bimmunological+memory%26%23x2019%3B.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000560-Knossow1" id="pone.0000560-Knossow1"></a>Knossow M, Skehel JJ (2006) Variation and infectivity neutralization in influenza. Immunology  119: 1–7.  <ul class="find" data-citedArticleID="961570" data-doi="10.1111/j.1365-2567.2006.02421.x"><li><a href="http://dx.doi.org/10.1111/j.1365-2567.2006.02421.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Variation+and+infectivity+neutralization+in+influenza." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Variation+and+infectivity+neutralization+in+influenza.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000560-Pantophlet1" id="pone.0000560-Pantophlet1"></a>Pantophlet R, Burton DRGP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol  24: 739–769.  <ul class="find" data-citedArticleID="961600" data-doi="10.1146/annurev.immunol.24.021605.090557"><li><a href="http://dx.doi.org/10.1146/annurev.immunol.24.021605.090557" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=GP120%3A+target+for+neutralizing+HIV-1+antibodies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22GP120%3A+target+for+neutralizing+HIV-1+antibodies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000560-Yao1" id="pone.0000560-Yao1"></a>Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer  35: 35–42.  <ul class="find" data-citedArticleID="961634" data-doi="10.1002/ijc.2910350107"><li><a href="http://dx.doi.org/10.1002/ijc.2910350107" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+re-examination+of+the+Epstein-Barr+virus+carrier+state+in+healthy+seropositive+individuals." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+re-examination+of+the+Epstein-Barr+virus+carrier+state+in+healthy+seropositive+individuals.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000560-Yoshino1" id="pone.0000560-Yoshino1"></a>Yoshino K, Taniguchi S (1965) Studies on the neutralization of herpes simplex virus. i. appearance of neutralizing antibodies having different grades of complement requirement. Virology  26: 44–53.  <ul class="find" data-citedArticleID="961638" data-doi="10.1016/0042-6822(65)90024-3"><li><a href="http://dx.doi.org/10.1016/0042-6822(65)90024-3" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Studies+on+the+neutralization+of+herpes+simplex+virus.+i.+appearance+of+neutralizing+antibodies+having+different+grades+of+complement+requirement." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Studies+on+the+neutralization+of+herpes+simplex+virus.+i.+appearance+of+neutralizing+antibodies+having+different+grades+of+complement+requirement.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000560-Martos1" id="pone.0000560-Martos1"></a>Martos LM, Ablashi DV, Gilden RV, Siguenza RF, Hampar B (1970) Preparation of immune rabbit sera with neutralizing activity against human cytomegalovirus and varicella-zoster virus. J Gen Virol  7: 169–171.  <ul class="find" data-citedArticleID="961586" data-doi="10.1099/0022-1317-7-2-169"><li><a href="http://dx.doi.org/10.1099/0022-1317-7-2-169" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Preparation+of+immune+rabbit+sera+with+neutralizing+activity+against+human+cytomegalovirus+and+varicella-zoster+virus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Preparation+of+immune+rabbit+sera+with+neutralizing+activity+against+human+cytomegalovirus+and+varicella-zoster+virus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000560-Miller1" id="pone.0000560-Miller1"></a>Miller G, Niederman JC, Stitt DA (1972) Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. J Infect Dis  125: 403–406.  <ul class="find" data-citedArticleID="961596" data-doi="10.1093/infdis/125.4.403"><li><a href="http://dx.doi.org/10.1093/infdis/125.4.403" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Infectious+mononucleosis%3A+appearance+of+neutralizing+antibody+to+Epstein-Barr+virus+measured+by+inhibition+of+formation+of+lymphoblastoid+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Infectious+mononucleosis%3A+appearance+of+neutralizing+antibody+to+Epstein-Barr+virus+measured+by+inhibition+of+formation+of+lymphoblastoid+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000560-Dialyna1" id="pone.0000560-Dialyna1"></a>Dialyna IA, Graham D, Rezaee R, Blue CE, Stavrianeas NG, et al.  (2004) Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro. AIDS  18: 1263–1270.  <ul class="find" data-citedArticleID="961546" data-doi="10.1097/00002030-200406180-00004"><li><a href="http://dx.doi.org/10.1097/00002030-200406180-00004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Anti-HHV-8%2FKSHV+antibodies+in+infected+individuals+inhibit+infection+in+vitro." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Anti-HHV-8%2FKSHV+antibodies+in+infected+individuals+inhibit+infection+in+vitro.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000560-Blaskovic1" id="pone.0000560-Blaskovic1"></a>Blaskovic D, Stancekova M, Svobodova J, Mistrikova J (1980) Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol  24: 468.  <ul class="find" data-citedArticleID="961534"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Isolation+of+five+strains+of+herpesviruses+from+two+species+of+free+living+small+rodents.&amp;auth=&amp;atitle=Isolation+of+five+strains+of+herpesviruses+from+two+species+of+free+living+small+rodents." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Isolation+of+five+strains+of+herpesviruses+from+two+species+of+free+living+small+rodents." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Isolation+of+five+strains+of+herpesviruses+from+two+species+of+free+living+small+rodents.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000560-Speck1" id="pone.0000560-Speck1"></a>Speck SH, Virgin HW (1999) Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol  2: 403–409.  <ul class="find" data-citedArticleID="961610" data-doi="10.1016/s1369-5274(99)80071-x"><li><a href="http://dx.doi.org/10.1016/s1369-5274(99)80071-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Host+and+viral+genetics+of+chronic+infection%3A+a+mouse+model+of+gamma-herpesvirus+pathogenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Host+and+viral+genetics+of+chronic+infection%3A+a+mouse+model+of+gamma-herpesvirus+pathogenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000560-Flano1" id="pone.0000560-Flano1"></a>Flano E, Woodland DL, Blackman MA (2002) A mouse model for infectious mononucleosis. Immunol Res  25: 201–217.  <ul class="find" data-citedArticleID="961550" data-doi="10.1385/ir:25:3:201"><li><a href="http://dx.doi.org/10.1385/ir:25:3:201" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+mouse+model+for+infectious+mononucleosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+mouse+model+for+infectious+mononucleosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000560-Stevenson1" id="pone.0000560-Stevenson1"></a>Stevenson PG, Boname JM, de Lima B, Efstathiou S (2002) A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect  4: 1177–1182.  <ul class="find" data-citedArticleID="961612" data-doi="10.1016/s1286-4579(02)01643-x"><li><a href="http://dx.doi.org/10.1016/s1286-4579(02)01643-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+battle+for+survival%3A+immune+control+and+immune+evasion+in+murine+gamma-herpesvirus-68+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+battle+for+survival%3A+immune+control+and+immune+evasion+in+murine+gamma-herpesvirus-68+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000560-Cardin1" id="pone.0000560-Cardin1"></a>Cardin RD, Brooks JW, Sarawar SR, Doherty PC (1996) Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med  184: 863–871.  <ul class="find" data-citedArticleID="961538" data-doi="10.1084/jem.184.3.863"><li><a href="http://dx.doi.org/10.1084/jem.184.3.863" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Progressive+loss+of+CD8%2B+T+cell-mediated+control+of+a+gamma-herpesvirus+in+the+absence+of+CD4%2B+T+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Progressive+loss+of+CD8%2B+T+cell-mediated+control+of+a+gamma-herpesvirus+in+the+absence+of+CD4%2B+T+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000560-DalCanto1" id="pone.0000560-DalCanto1"></a>Dal Canto AJ, Virgin HW, Speck SH (2000) Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol  74: 11304–11310.  <ul class="find" data-citedArticleID="961544" data-doi="10.1128/jvi.74.23.11304-11310.2000"><li><a href="http://dx.doi.org/10.1128/jvi.74.23.11304-11310.2000" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ongoing+viral+replication+is+required+for+gammaherpesvirus+68-induced+vascular+damage." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ongoing+viral+replication+is+required+for+gammaherpesvirus+68-induced+vascular+damage.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000560-Christensen1" id="pone.0000560-Christensen1"></a>Christensen JP, Cardin RD, Branum KC, Doherty PC (1999) CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A  96: 5135–5140.  <ul class="find" data-citedArticleID="961540" data-doi="10.1073/pnas.96.9.5135"><li><a href="http://dx.doi.org/10.1073/pnas.96.9.5135" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CD4%28%2B%29+T+cell-mediated+control+of+a+gamma-herpesvirus+in+B+cell-deficient+mice+is+mediated+by+IFN-gamma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CD4%28%2B%29+T+cell-mediated+control+of+a+gamma-herpesvirus+in+B+cell-deficient+mice+is+mediated+by+IFN-gamma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000560-Stevenson2" id="pone.0000560-Stevenson2"></a>Stevenson PG, Cardin RD, Christensen JP, Doherty PC (1999) Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol  80: 477–483.  <ul class="find" data-citedArticleID="961614"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Immunological+control+of+a+murine+gammaherpesvirus+independent+of+CD8%2B+T+cells.&amp;auth=&amp;atitle=Immunological+control+of+a+murine+gammaherpesvirus+independent+of+CD8%2B+T+cells." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immunological+control+of+a+murine+gammaherpesvirus+independent+of+CD8%2B+T+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immunological+control+of+a+murine+gammaherpesvirus+independent+of+CD8%2B+T+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000560-Ehtisham1" id="pone.0000560-Ehtisham1"></a>Ehtisham S, Sunil-Chandra NP, Nash AA (1993) Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol  67: 5247–5252.  <ul class="find" data-citedArticleID="961548"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Pathogenesis+of+murine+gammaherpesvirus+infection+in+mice+deficient+in+CD4+and+CD8+T+cells.&amp;auth=&amp;atitle=Pathogenesis+of+murine+gammaherpesvirus+infection+in+mice+deficient+in+CD4+and+CD8+T+cells." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pathogenesis+of+murine+gammaherpesvirus+infection+in+mice+deficient+in+CD4+and+CD8+T+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pathogenesis+of+murine+gammaherpesvirus+infection+in+mice+deficient+in+CD4+and+CD8+T+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000560-Stewart1" id="pone.0000560-Stewart1"></a>Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T (1998) Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med  187: 1941–1951.  <ul class="find" data-citedArticleID="961628" data-doi="10.1084/jem.187.12.1941"><li><a href="http://dx.doi.org/10.1084/jem.187.12.1941" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lung+epithelial+cells+are+a+major+site+of+murine+gammaherpesvirus+persistence." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lung+epithelial+cells+are+a+major+site+of+murine+gammaherpesvirus+persistence.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000560-Kim1" id="pone.0000560-Kim1"></a>Kim IJ, Flano E, Woodland DL, Blackman MA (2002) Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol  168: 3958–3964.  <ul class="find" data-citedArticleID="961568"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Antibody-mediated+control+of+persistent+gamma-herpesvirus+infection.&amp;auth=&amp;atitle=Antibody-mediated+control+of+persistent+gamma-herpesvirus+infection." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Antibody-mediated+control+of+persistent+gamma-herpesvirus+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Antibody-mediated+control+of+persistent+gamma-herpesvirus+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000560-Gangappa1" id="pone.0000560-Gangappa1"></a>Gangappa S, Kapadia SB, Speck SH, Virgin HW (2000) Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol  76: 11460–11468.  <ul class="find" data-citedArticleID="961556" data-doi="10.1128/jvi.76.22.11460-11468.2002"><li><a href="http://dx.doi.org/10.1128/jvi.76.22.11460-11468.2002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Antibody+to+a+lytic+cycle+viral+protein+decreases+gammaherpesvirus+latency+in+B-cell-deficient+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Antibody+to+a+lytic+cycle+viral+protein+decreases+gammaherpesvirus+latency+in+B-cell-deficient+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000560-Stevenson3" id="pone.0000560-Stevenson3"></a>Stevenson PG, May JS, Smith XG, Marques S, Adler H, et al.  (2002) K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol  3: 733–740.  <ul class="find" data-citedArticleID="961616" data-doi="10.1038/ni818"><li><a href="http://dx.doi.org/10.1038/ni818" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=K3-mediated+evasion+of+CD8%28%2B%29+T+cells+aids+amplification+of+a+latent+gamma-herpesvirus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22K3-mediated+evasion+of+CD8%28%2B%29+T+cells+aids+amplification+of+a+latent+gamma-herpesvirus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000560-Stevenson4" id="pone.0000560-Stevenson4"></a>Stevenson PG (2004) Immune evasion by gamma-herpesviruses. Curr Opin Immunol  16: 456–462.  <ul class="find" data-citedArticleID="961618" data-doi="10.1016/j.coi.2004.05.002"><li><a href="http://dx.doi.org/10.1016/j.coi.2004.05.002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immune+evasion+by+gamma-herpesviruses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immune+evasion+by+gamma-herpesviruses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000560-Kohl1" id="pone.0000560-Kohl1"></a>Kohl S, Loo LS (1982) Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity. J Immunol  129: 370–376.  <ul class="find" data-citedArticleID="961572"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Protection+of+neonatal+mice+against+herpes+simplex+virus+infection%3A+probable+in+vivo+antibody-dependent+cellular+cytotoxicity.&amp;auth=&amp;atitle=Protection+of+neonatal+mice+against+herpes+simplex+virus+infection%3A+probable+in+vivo+antibody-dependent+cellular+cytotoxicity." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Protection+of+neonatal+mice+against+herpes+simplex+virus+infection%3A+probable+in+vivo+antibody-dependent+cellular+cytotoxicity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Protection+of+neonatal+mice+against+herpes+simplex+virus+infection%3A+probable+in+vivo+antibody-dependent+cellular+cytotoxicity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000560-Sissons1" id="pone.0000560-Sissons1"></a>Sissons JG, Oldstone MB (1980) Killing of virus-infected cells: the role of antiviral antibody and complement in limiting virus infection. J Infect Dis  142: 442–448.  <ul class="find" data-citedArticleID="961608" data-doi="10.1093/infdis/142.3.442"><li><a href="http://dx.doi.org/10.1093/infdis/142.3.442" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Killing+of+virus-infected+cells%3A+the+role+of+antiviral+antibody+and+complement+in+limiting+virus+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Killing+of+virus-infected+cells%3A+the+role+of+antiviral+antibody+and+complement+in+limiting+virus+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000560-Stevenson5" id="pone.0000560-Stevenson5"></a>Stevenson PG, Doherty PC (1998) Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol  72: 943–949.  <ul class="find" data-citedArticleID="961620"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Kinetic+analysis+of+the+specific+host+response+to+a+murine+gammaherpesvirus.&amp;auth=&amp;atitle=Kinetic+analysis+of+the+specific+host+response+to+a+murine+gammaherpesvirus." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Kinetic+analysis+of+the+specific+host+response+to+a+murine+gammaherpesvirus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Kinetic+analysis+of+the+specific+host+response+to+a+murine+gammaherpesvirus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000560-Stevenson6" id="pone.0000560-Stevenson6"></a>Stevenson PG, Doherty PC (1999) Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol  73: 1075–1079.  <ul class="find" data-citedArticleID="961622"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Non-antigen-specific+B-cell+activation+following+murine+gammaherpesvirus+infection+is+CD4+independent+in+vitro+but+CD4+dependent+in+vivo.&amp;auth=&amp;atitle=Non-antigen-specific+B-cell+activation+following+murine+gammaherpesvirus+infection+is+CD4+independent+in+vitro+but+CD4+dependent+in+vivo." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Non-antigen-specific+B-cell+activation+following+murine+gammaherpesvirus+infection+is+CD4+independent+in+vitro+but+CD4+dependent+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Non-antigen-specific+B-cell+activation+following+murine+gammaherpesvirus+infection+is+CD4+independent+in+vitro+but+CD4+dependent+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000560-Gill1" id="pone.0000560-Gill1"></a>Gill MB, Gillet L, Colaco S, May JS, de Lima BD, et al.  (2006) Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies. J Gen Virol  87: 1465–1475.  <ul class="find" data-citedArticleID="961558" data-doi="10.1099/vir.0.81760-0"><li><a href="http://dx.doi.org/10.1099/vir.0.81760-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Murine+gammaherpesvirus-68+glycoprotein+H-glycoprotein+L+complex+is+a+major+target+for+neutralizing+monoclonal+antibodies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Murine+gammaherpesvirus-68+glycoprotein+H-glycoprotein+L+complex+is+a+major+target+for+neutralizing+monoclonal+antibodies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000560-Peiris1" id="pone.0000560-Peiris1"></a>Peiris JS, Porterfield JS (1979) Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature  282: 509–511.  <ul class="find" data-citedArticleID="961602" data-doi="10.1038/282509a0"><li><a href="http://dx.doi.org/10.1038/282509a0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Antibody-mediated+enhancement+of+Flavivirus+replication+in+macrophage-like+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Antibody-mediated+enhancement+of+Flavivirus+replication+in+macrophage-like+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000560-Iankov1" id="pone.0000560-Iankov1"></a>Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, et al.  (2006) Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol  80: 8530–8540.  <ul class="find" data-citedArticleID="961566" data-doi="10.1128/jvi.00593-06"><li><a href="http://dx.doi.org/10.1128/jvi.00593-06" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immunoglobulin+g+antibody-mediated+enhancement+of+measles+virus+infection+can+bypass+the+protective+antiviral+immune+response." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immunoglobulin+g+antibody-mediated+enhancement+of+measles+virus+infection+can+bypass+the+protective+antiviral+immune+response.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000560-Weck1" id="pone.0000560-Weck1"></a>Weck KE, Kim SS, Virgin HW, Speck SH (1999) Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol  73: 3273–3283.  <ul class="find" data-citedArticleID="961632"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Macrophages+are+the+major+reservoir+of+latent+murine+gammaherpesvirus+68+in+peritoneal+cells.&amp;auth=&amp;atitle=Macrophages+are+the+major+reservoir+of+latent+murine+gammaherpesvirus+68+in+peritoneal+cells." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Macrophages+are+the+major+reservoir+of+latent+murine+gammaherpesvirus+68+in+peritoneal+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Macrophages+are+the+major+reservoir+of+latent+murine+gammaherpesvirus+68+in+peritoneal+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0000560-Flano2" id="pone.0000560-Flano2"></a>Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA (2000) Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol  165: 1074–1081.  <ul class="find" data-citedArticleID="961552"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Latent+murine+gamma-herpesvirus+infection+is+established+in+activated+B+cells%2C+dendritic+cells%2C+and+macrophages.&amp;auth=&amp;atitle=Latent+murine+gamma-herpesvirus+infection+is+established+in+activated+B+cells%2C+dendritic+cells%2C+and+macrophages." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Latent+murine+gamma-herpesvirus+infection+is+established+in+activated+B+cells%2C+dendritic+cells%2C+and+macrophages." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Latent+murine+gamma-herpesvirus+infection+is+established+in+activated+B+cells%2C+dendritic+cells%2C+and+macrophages.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000560-Niess1" id="pone.0000560-Niess1"></a>Niess JH, Brand S, Gu X, Landsman L, Jung S, et al.  (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science  307: 254–258.  <ul class="find" data-citedArticleID="961598" data-doi="10.1126/science.1102901"><li><a href="http://dx.doi.org/10.1126/science.1102901" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CX3CR1-mediated+dendritic+cell+access+to+the+intestinal+lumen+and+bacterial+clearance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CX3CR1-mediated+dendritic+cell+access+to+the+intestinal+lumen+and+bacterial+clearance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000560-Qiao1" id="pone.0000560-Qiao1"></a>Qiao SW, Lencer WI, Blumberg RS (2007) How the controller is controlled-neonatal Fc receptor expression and immunoglobulin G homeostasis. Immunology  120: 145–147.  <ul class="find" data-citedArticleID="961604" data-doi="10.1111/j.1365-2567.2006.02507.x"><li><a href="http://dx.doi.org/10.1111/j.1365-2567.2006.02507.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=How+the+controller+is+controlled-neonatal+Fc+receptor+expression+and+immunoglobulin+G+homeostasis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22How+the+controller+is+controlled-neonatal+Fc+receptor+expression+and+immunoglobulin+G+homeostasis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0000560-Maidji1" id="pone.0000560-Maidji1"></a>Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol  168: 1210–1226.  <ul class="find" data-citedArticleID="961584" data-doi="10.2353/ajpath.2006.050482"><li><a href="http://dx.doi.org/10.2353/ajpath.2006.050482" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Maternal+antibodies+enhance+or+prevent+cytomegalovirus+infection+in+the+placenta+by+neonatal+Fc+receptor-mediated+transcytosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Maternal+antibodies+enhance+or+prevent+cytomegalovirus+infection+in+the+placenta+by+neonatal+Fc+receptor-mediated+transcytosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0000560-Adler1" id="pone.0000560-Adler1"></a>Adler H, Messerle M, Wagner M, Koszinowski UH (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol  74: 6964–6974.  <ul class="find" data-citedArticleID="961530" data-doi="10.1128/jvi.74.15.6964-6974.2000"><li><a href="http://dx.doi.org/10.1128/jvi.74.15.6964-6974.2000" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cloning+and+mutagenesis+of+the+murine+gammaherpesvirus+68+genome+as+an+infectious+bacterial+artificial+chromosome." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cloning+and+mutagenesis+of+the+murine+gammaherpesvirus+68+genome+as+an+infectious+bacterial+artificial+chromosome.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0000560-Gillet1" id="pone.0000560-Gillet1"></a>Gillet L, Gill MB, Colaco S, Smith CM, Stevenson PG (2006) Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol  87: 3515–3527.  <ul class="find" data-citedArticleID="961560" data-doi="10.1099/vir.0.82313-0"><li><a href="http://dx.doi.org/10.1099/vir.0.82313-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Murine+gammaherpesvirus-68+glycoprotein+B+presents+a+difficult+neutralization+target+to+monoclonal+antibodies+derived+from+infected+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Murine+gammaherpesvirus-68+glycoprotein+B+presents+a+difficult+neutralization+target+to+monoclonal+antibodies+derived+from+infected+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0000560-Coleman1" id="pone.0000560-Coleman1"></a>Coleman HM, Efstathiou S, Stevenson PG (2005) Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats. J Gen Virol  86: 561–574.  <ul class="find" data-citedArticleID="961542" data-doi="10.1099/vir.0.80565-0"><li><a href="http://dx.doi.org/10.1099/vir.0.80565-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transcription+of+the+murine+gammaherpesvirus+68+ORF73+from+promoters+in+the+viral+terminal+repeats." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transcription+of+the+murine+gammaherpesvirus+68+ORF73+from+promoters+in+the+viral+terminal+repeats.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0000560-Bennett1" id="pone.0000560-Bennett1"></a>Bennett NJ, May JS, Stevenson PG (2005) Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol  3: e120.  <ul class="find" data-citedArticleID="961532" data-doi="10.1371/journal.pbio.0030120"><li><a href="http://dx.doi.org/10.1371/journal.pbio.0030120" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gamma-herpesvirus+latency+requires+T+cell+evasion+during+episome+maintenance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gamma-herpesvirus+latency+requires+T+cell+evasion+during+episome+maintenance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0000560-Lee1" id="pone.0000560-Lee1"></a>Lee Y, Sohn WJ, Kim DS, Kwon HJ (2004) NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7. Eur J Biochem  271: 1094–1105.  <ul class="find" data-citedArticleID="961576" data-doi="10.1111/j.1432-1033.2004.04011.x"><li><a href="http://dx.doi.org/10.1111/j.1432-1033.2004.04011.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=NF-kappaB-+and+c-Jun-dependent+regulation+of+human+cytomegalovirus+immediate-early+gene+enhancer%2Fpromoter+in+response+to+lipopolysaccharide+and+bacterial+CpG-oligodeoxynucleotides+in+macrophage+cell+line+RAW+264.7." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22NF-kappaB-+and+c-Jun-dependent+regulation+of+human+cytomegalovirus+immediate-early+gene+enhancer%2Fpromoter+in+response+to+lipopolysaccharide+and+bacterial+CpG-oligodeoxynucleotides+in+macrophage+cell+line+RAW+264.7.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0000560-May1" id="pone.0000560-May1"></a>May JS, Colaco S, Stevenson PG (2005) Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68. J Virol  79: 3459–3467.  <ul class="find" data-citedArticleID="961588" data-doi="10.1128/jvi.79.6.3459-3467.2005"><li><a href="http://dx.doi.org/10.1128/jvi.79.6.3459-3467.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Glycoprotein+M+is+an+essential+lytic+replication+protein+of+the+murine+gammaherpesvirus+68." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Glycoprotein+M+is+an+essential+lytic+replication+protein+of+the+murine+gammaherpesvirus+68.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0000560-Boname1" id="pone.0000560-Boname1"></a>Boname JM, de Lima BD, Lehner PJ, Stevenson PG (2004) Viral degradation of the MHC class I peptide loading complex. Immunity  20: 305–317.  <ul class="find" data-citedArticleID="961536" data-doi="10.1016/s1074-7613(04)00047-0"><li><a href="http://dx.doi.org/10.1016/s1074-7613(04)00047-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Viral+degradation+of+the+MHC+class+I+peptide+loading+complex." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Viral+degradation+of+the+MHC+class+I+peptide+loading+complex.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0000560-Stevenson7" id="pone.0000560-Stevenson7"></a>Stevenson PG, Belz GT, Castrucci MR, Altman JD, Doherty PC (1999) A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A.  96: 9281–9286.  <ul class="find" data-citedArticleID="961624" data-doi="10.1073/pnas.96.16.9281"><li><a href="http://dx.doi.org/10.1073/pnas.96.16.9281" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+gamma-herpesvirus+sneaks+through+a+CD8%28%2B%29+T+cell+response+primed+to+a+lytic-phase+epitope." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+gamma-herpesvirus+sneaks+through+a+CD8%28%2B%29+T+cell+response+primed+to+a+lytic-phase+epitope.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0000560-Lubinski1" id="pone.0000560-Lubinski1"></a>Lubinski JM, Jiang M, Hook L, Chang Y, Sarver C, et al.  (2002) Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J Virol  76: 9232–9241.  <ul class="find" data-citedArticleID="961582" data-doi="10.1128/jvi.76.18.9232-9241.2002"><li><a href="http://dx.doi.org/10.1128/jvi.76.18.9232-9241.2002" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Herpes+simplex+virus+type+1+evades+the+effects+of+antibody+and+complement+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Herpes+simplex+virus+type+1+evades+the+effects+of+antibody+and+complement+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0000560-Yao2" id="pone.0000560-Yao2"></a>Yao QY, Rowe M, Morgan AJ, Sam CK, Prasad U, et al.  (1991) Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization. Int J Cancer  48: 45–50.  <ul class="find" data-citedArticleID="961636" data-doi="10.1002/ijc.2910480109"><li><a href="http://dx.doi.org/10.1002/ijc.2910480109" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Salivary+and+serum+IgA+antibodies+to+the+Epstein-Barr+virus+glycoprotein+gp340%3A+incidence+and+potential+for+virus+neutralization." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Salivary+and+serum+IgA+antibodies+to+the+Epstein-Barr+virus+glycoprotein+gp340%3A+incidence+and+potential+for+virus+neutralization.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">45.
              </span><a name="pone.0000560-Sangster1" id="pone.0000560-Sangster1"></a>Sangster MY, Topham DJ, D'Costa S, Cardin RD, Marion TN, et al.  (2000) Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol  164: 1820–1828.  <ul class="find" data-citedArticleID="961606"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Analysis+of+the+virus-specific+and+nonspecific+B+cell+response+to+a+persistent+B-lymphotropic+gammaherpesvirus.&amp;auth=&amp;atitle=Analysis+of+the+virus-specific+and+nonspecific+B+cell+response+to+a+persistent+B-lymphotropic+gammaherpesvirus." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Analysis+of+the+virus-specific+and+nonspecific+B+cell+response+to+a+persistent+B-lymphotropic+gammaherpesvirus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Analysis+of+the+virus-specific+and+nonspecific+B+cell+response+to+a+persistent+B-lymphotropic+gammaherpesvirus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">46.
              </span><a name="pone.0000560-MbopiKeou1" id="pone.0000560-MbopiKeou1"></a>Mbopi-Keou FX, Legoff J, Piketty C, Hocini H, Malkin JE, et al.  (2004) Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressed. AIDS.  18: 338–340.  <ul class="find" data-citedArticleID="961594" data-doi="10.1097/00002030-200401230-00030"><li><a href="http://dx.doi.org/10.1097/00002030-200401230-00030" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Salivary+production+of+IgA+and+IgG+to+human+herpes+virus+8+latent+and+lytic+antigens+by+patients+in+whom+Kaposi%27s+sarcoma+has+regressed." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Salivary+production+of+IgA+and+IgG+to+human+herpes+virus+8+latent+and+lytic+antigens+by+patients+in+whom+Kaposi%27s+sarcoma+has+regressed.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">47.
              </span><a name="pone.0000560-Kraehenbuhl1" id="pone.0000560-Kraehenbuhl1"></a>Kraehenbuhl JP, Neutra MR (2000) Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol  16: 301–332.  <ul class="find" data-citedArticleID="961574" data-doi="10.1146/annurev.cellbio.16.1.301"><li><a href="http://dx.doi.org/10.1146/annurev.cellbio.16.1.301" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Epithelial+M+cells%3A+differentiation+and+function." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Epithelial+M+cells%3A+differentiation+and+function.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">48.
              </span><a name="pone.0000560-vanMontfort1" id="pone.0000560-vanMontfort1"></a>van Montfort T, Nabatov AA, Geijtenbeek TB, Pollakis G, Paxton WA (2007) Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J Immunol  178: 3177–3185.  <ul class="find" data-citedArticleID="961644"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Efficient+capture+of+antibody+neutralized+HIV-1+by+cells+expressing+DC-SIGN+and+transfer+to+CD4%2B+T+lymphocytes.&amp;auth=&amp;atitle=Efficient+capture+of+antibody+neutralized+HIV-1+by+cells+expressing+DC-SIGN+and+transfer+to+CD4%2B+T+lymphocytes." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Efficient+capture+of+antibody+neutralized+HIV-1+by+cells+expressing+DC-SIGN+and+transfer+to+CD4%2B+T+lymphocytes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Efficient+capture+of+antibody+neutralized+HIV-1+by+cells+expressing+DC-SIGN+and+transfer+to+CD4%2B+T+lymphocytes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">49.
              </span><a name="pone.0000560-SunilChandra1" id="pone.0000560-SunilChandra1"></a>Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA (1992) Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol  73: 2347–2356.  <ul class="find" data-citedArticleID="961630" data-doi="10.1099/0022-1317-73-9-2347"><li><a href="http://dx.doi.org/10.1099/0022-1317-73-9-2347" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Virological+and+pathological+features+of+mice+infected+with+murine+gamma-herpesvirus+68." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Virological+and+pathological+features+of+mice+infected+with+murine+gamma-herpesvirus+68.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">50.
              </span><a name="pone.0000560-deLima1" id="pone.0000560-deLima1"></a>de Lima BD, May JS, Stevenson PG (2004) Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol  78: 5103–5112.  <ul class="find" data-citedArticleID="961642" data-doi="10.1128/jvi.78.10.5103-5112.2004"><li><a href="http://dx.doi.org/10.1128/jvi.78.10.5103-5112.2004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Murine+gammaherpesvirus+68+lacking+gp150+shows+defective+virion+release+but+establishes+normal+latency+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Murine+gammaherpesvirus+68+lacking+gp150+shows+defective+virion+release+but+establishes+normal+latency+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">51.
              </span><a name="pone.0000560-Gillet2" id="pone.0000560-Gillet2"></a>Gillet L, May JS, Colaco S, Stevenson PG (2007) Glycoprotein L disruption reveals 2 functional forms of the murine gammaherpesvirus-68 glycoprotein H. J Virol  81: 280–291.  <ul class="find" data-citedArticleID="961562" data-doi="10.1128/jvi.01616-06"><li><a href="http://dx.doi.org/10.1128/jvi.01616-06" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Glycoprotein+L+disruption+reveals+2+functional+forms+of+the+murine+gammaherpesvirus-68+glycoprotein+H." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Glycoprotein+L+disruption+reveals+2+functional+forms+of+the+murine+gammaherpesvirus-68+glycoprotein+H.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">52.
              </span><a name="pone.0000560-Galfre1" id="pone.0000560-Galfre1"></a>Galfre G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol  73: 3–46.  <ul class="find" data-citedArticleID="961554" data-doi="10.1016/0076-6879(81)73054-4"><li><a href="http://dx.doi.org/10.1016/0076-6879(81)73054-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Preparation+of+monoclonal+antibodies%3A+strategies+and+procedures." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Preparation+of+monoclonal+antibodies%3A+strategies+and+procedures.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">53.
              </span><a name="pone.0000560-Gillet3" id="pone.0000560-Gillet3"></a>Gillet L, Adler H, Stevenson PG (2007) Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS ONE  2: e347.  <ul class="find" data-citedArticleID="961564" data-doi="10.1371/journal.pone.0000347"><li><a href="http://dx.doi.org/10.1371/journal.pone.0000347" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Glycosaminoglycan+interactions+in+murine+gammaherpesvirus-68+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Glycosaminoglycan+interactions+in+murine+gammaherpesvirus-68+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">54.
              </span><a name="pone.0000560-May2" id="pone.0000560-May2"></a>May JS, Walker J, Colaco S, Stevenson PG (2005) The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread. J Virol  79: 5059–5068.  <ul class="find" data-citedArticleID="961590" data-doi="10.1128/jvi.79.8.5059-5068.2005"><li><a href="http://dx.doi.org/10.1128/jvi.79.8.5059-5068.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+murine+gammaherpesvirus+68+ORF27+gene+product+contributes+to+intercellular+viral+spread." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+murine+gammaherpesvirus+68+ORF27+gene+product+contributes+to+intercellular+viral+spread.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">55.
              </span><a name="pone.0000560-May3" id="pone.0000560-May3"></a>May JS, de Lima BD, Colaco S, Stevenson PG (2005) Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport. Traffic  6: 780–793.  <ul class="find" data-citedArticleID="961592" data-doi="10.1111/j.1600-0854.2005.00316.x"><li><a href="http://dx.doi.org/10.1111/j.1600-0854.2005.00316.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Intercellular+gamma-herpesvirus+dissemination+involves+co-ordinated+intracellular+membrane+protein+transport." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Intercellular+gamma-herpesvirus+dissemination+involves+co-ordinated+intracellular+membrane+protein+transport.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">56.
              </span><a name="pone.0000560-Lopes1" id="pone.0000560-Lopes1"></a>Lopes FB, Colaco S, May JS, Stevenson PG (2004) Characterization of murine gammaherpesvirus 68 glycoprotein B. J Virol  78: 13370–13375.  <ul class="find" data-citedArticleID="961580" data-doi="10.1128/jvi.78.23.13370-13375.2004"><li><a href="http://dx.doi.org/10.1128/jvi.78.23.13370-13375.2004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Characterization+of+murine+gammaherpesvirus+68+glycoprotein+B." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Characterization+of+murine+gammaherpesvirus+68+glycoprotein+B.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">57.
              </span><a name="pone.0000560-Stevenson8" id="pone.0000560-Stevenson8"></a>Stevenson PG, Belz GT, Altman JD, Doherty PC (1999) Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol  29: 1059–1067.  <ul class="find" data-citedArticleID="961626" data-doi="10.1002/(sici)1521-4141(199904)29:04<1059::aid-immu1059&gt;3.0.co;2-l"><li><a href="http://dx.doi.org/10.1002/(sici)1521-4141(199904)29:04<1059::aid-immu1059&gt;3.0.co;2-l" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Changing+patterns+of+dominance+in+the+CD8%2B+T+cell+response+during+acute+and+persistent+murine+gamma-herpesvirus+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Changing+patterns+of+dominance+in+the+CD8%2B+T+cell+response+during+acute+and+persistent+murine+gamma-herpesvirus+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">58.
              </span><a name="pone.0000560-Liu1" id="pone.0000560-Liu1"></a>Liu L, Flano E, Usherwood EJ, Surman S, Blackman MA, et al.  (1999) Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J Immunol  163: 868–874.  <ul class="find" data-citedArticleID="961578"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Lytic+cycle+T+cell+epitopes+are+expressed+in+two+distinct+phases+during+MHV-68+infection.&amp;auth=&amp;atitle=Lytic+cycle+T+cell+epitopes+are+expressed+in+two+distinct+phases+during+MHV-68+infection." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lytic+cycle+T+cell+epitopes+are+expressed+in+two+distinct+phases+during+MHV-68+infection." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lytic+cycle+T+cell+epitopes+are+expressed+in+two+distinct+phases+during+MHV-68+infection.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.XML" value="107946"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.PDF" value="681066"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g001.PNG_L" value="805372"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g001.PNG_M" value="33910"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g001.PNG_S" value="4265"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g001.TIF" value="1085724"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g001.PNG_I" value="50144"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g002.PNG_L" value="321156"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g002.PNG_M" value="23327"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g002.PNG_S" value="2125"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g002.TIF" value="558462"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g002.PNG_I" value="9510"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g003.PNG_L" value="406188"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g003.PNG_M" value="22234"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g003.PNG_S" value="3037"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g003.TIF" value="793222"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g003.PNG_I" value="11518"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g004.PNG_L" value="392677"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g004.PNG_M" value="15071"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g004.PNG_S" value="3831"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g004.TIF" value="695634"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g005.PNG_L" value="141511"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g005.PNG_M" value="9595"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g005.PNG_S" value="2233"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g005.TIF" value="336828"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g005.PNG_I" value="5657"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g006.PNG_L" value="3397221"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g006.PNG_M" value="180846"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g006.PNG_S" value="6564"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g006.TIF" value="4992486"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g006.PNG_I" value="84100"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g007.PNG_L" value="2220852"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g007.PNG_M" value="116613"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g007.PNG_S" value="9424"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g007.TIF" value="3083442"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g007.PNG_I" value="104501"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g008.PNG_L" value="427824"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g008.PNG_M" value="30106"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g008.PNG_S" value="2546"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g008.TIF" value="760332"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g008.PNG_I" value="14731"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g009.PNG_L" value="1589448"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g009.PNG_M" value="85232"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g009.PNG_S" value="3971"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g009.TIF" value="2361430"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.g009.PNG_I" value="75688"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.t001.PNG_L" value="81404"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.t001.PNG_M" value="72164"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.t001.PNG_S" value="4436"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.t001.TIF" value="479224"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000560.t001.PNG_I" value="34862"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000560&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000560" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000560&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000560&volume=&issue=&title=IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68&author_name=Gustavo%20T.%20Rosa%2C%20Laurent%20Gillet%2C%20Christopher%20M.%20Smith%2C%20Brigitte%20D.%20de%20Lima%2C%20Philip%20G.%20Stevenson&start_page=1&end_page=11" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000560" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560&amp;t=IgG%20Fc%20Receptors%20Provide%20an%20Alternative%20Infection%20Route%20for%20Murine%20Gamma-Herpesvirus-68" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560&title=IgG%20Fc%20Receptors%20Provide%20an%20Alternative%20Infection%20Route%20for%20Murine%20Gamma-Herpesvirus-68&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560&amp;title=IgG%20Fc%20Receptors%20Provide%20an%20Alternative%20Infection%20Route%20for%20Murine%20Gamma-Herpesvirus-68" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000560&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000560';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20IgG%20Fc%20Receptors%20Provide%20an%20Alternative%20Infection%20Route%20for%20Murine%20Gamma-Herpesvirus-68 http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000560" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000560" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">





















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antibodies%22" title="Search for articles in the subject area:'Antibodies'"><div class="flagText">Antibodies</div></a>
              <div data-categoryid="47389" data-articleid="23958"
                   data-categoryname="Antibodies"
                   class="flagImage" title="Flag 'Antibodies' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+staining%22" title="Search for articles in the subject area:'Cell staining'"><div class="flagText">Cell staining</div></a>
              <div data-categoryid="17401" data-articleid="23958"
                   data-categoryname="Cell staining"
                   class="flagImage" title="Flag 'Cell staining' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Fibroblasts%22" title="Search for articles in the subject area:'Fibroblasts'"><div class="flagText">Fibroblasts</div></a>
              <div data-categoryid="47975" data-articleid="23958"
                   data-categoryname="Fibroblasts"
                   class="flagImage" title="Flag 'Fibroblasts' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Flow+cytometry%22" title="Search for articles in the subject area:'Flow cytometry'"><div class="flagText">Flow cytometry</div></a>
              <div data-categoryid="20135" data-articleid="23958"
                   data-categoryname="Flow cytometry"
                   class="flagImage" title="Flag 'Flow cytometry' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Immune+serum%22" title="Search for articles in the subject area:'Immune serum'"><div class="flagText">Immune serum</div></a>
              <div data-categoryid="49633" data-articleid="23958"
                   data-categoryname="Immune serum"
                   class="flagImage" title="Flag 'Immune serum' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Macrophages%22" title="Search for articles in the subject area:'Macrophages'"><div class="flagText">Macrophages</div></a>
              <div data-categoryid="19107" data-articleid="23958"
                   data-categoryname="Macrophages"
                   class="flagImage" title="Flag 'Macrophages' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Viral+replication%22" title="Search for articles in the subject area:'Viral replication'"><div class="flagText">Viral replication</div></a>
              <div data-categoryid="20015" data-articleid="23958"
                   data-categoryname="Viral replication"
                   class="flagImage" title="Flag 'Viral replication' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Virions%22" title="Search for articles in the subject area:'Virions'"><div class="flagText">Virions</div></a>
              <div data-categoryid="19387" data-articleid="23958"
                   data-categoryname="Virions"
                   class="flagImage" title="Flag 'Virions' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=6950'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=5937'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=2532&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=10545">Lack of lytic antigen does not indicate latency</a><br>Posted by virusdoc</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
